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Introduction 
 SIDDHA medicine is founded by Siddhars on the basic principle of nature 
and its elements after careful and thorough study of the human systems.  
 Siddhars are mainly responsible for the Tamil Medicine of the present day 
and also for many other sciences of public utility. They have invented the science 
of medicine in order to help the people to keep themselves in good health and thus 
to make themselves in good health and thus to make themselves fit to work hard 
for eternal salvation.  
 The word „Siddhar‟ means as one who attains perfection (Siddhi) in life arts 
such as philosophy. Yoga, Wisdom, Alchemy, Medicine and above all the art of 
longevity.  
 Thirumoolar was the first siddhar, who mentioned the fundamental 
philosophical Thathuvams like ten vayus, ten nadis in his treatise.  
 According to Thirumoolar,  
MEDICINE means one that ensures PHYSIOTHERAPHY 
MEDICINE means one that ensures PSYCHO THERAPHY 
MEDICINE means one that ensures Preventive against diseases.  
MEDICINE means one that ensures Preventive against mortality.  
       (Thirumoolar 800) 
The science of pulse, methods of diagnosis by eight kinds of clinical 
examination (Envagi thervu), the principle and philosophy of YOGA and alchemy 
are the distinctive features of siddha system. Siddha is claimed to be a philosophy 
of life and living. Its object is a counter act in balance of three essential ailments ie 
Vadham, Pitham and Kapam. 
 According to Dr. R. Thygarajan, this scientific system was based on the 
„THIRI DOSHA‟ humoral theory, akin to modern Endocrinology. This system 
was traditionally believed to have originated from the creator, the fountain head of 
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mercy, with his Three – fold functions of creation, preservation of good and 
destruction of evil. This goes very well with what is expressed in the words. “The 
physician treats, the god cures”. This system was spread to the world through 
sages, saints and haloed men. The siddha system grew through the works of 
Agaisthiar, Thirumoolar, Bogar, pulipani, Yugi, Theriar and others. It dealt with 
minerals, metals and herbs because chemistry was more advanced in the South 
then.  
 Vaidyaratna capt. G.Sreenivasamurthi B.A.B.L. M.B.CM then founder and 
(Principal of the Govt. School of Indian Medicine, Madras, said, “A day will soon 
come when through translations from the original difficult Tamil, people all over 
the world could understand the wonderful Siddha literature which is   still mostly a 
sealed book. Then the value of the BASPAMS and chendoorams and other 
preparations would come to be realized”.  
 Siddhars knowledge of Iatrochemistry, minerals, metals and plants was 
stupendous. This was successfully used by them from, time immemorial. The 
process like calcinations of mercury, minerals and metals and the preparation of a 
super salt known as “MUPPU”, animated mercury pills with high potency 
possessing marvellous properties of transmuting metals and capable of 
rejuvenating the entire human system, bear ample testimony to the fact that, even 
in the remote past, when knowledge in chemical technology was not fully 
developed siddhars had unparalled knowledge in medicine.  
 Recognition (Pharma cognosy) and collection of raw materials, preparation 
of medicines, methods of standardization including dosage studies, phyto 
chemistry, pharmacology, toxicology, teratogenicity, carcinogenticity, clinical 
trials and preparations on a mass scale have to be considered.  
 The materia medica of Siddha Medicine is divided into three major 
divisions namely Plant (or) vegetable kingdom, Metals, Minerals and animal 
kingdom. Among the animal species, sangu (conch shell, chank) plays a very 
important role in the preparation of Sangu Parpam, a medicine frequently 
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prescribed by all the Indian medicine Doctors for peptic ulcer (Gunmam in Siddha) 
and also for a wide variety of diseases like, Keel vayu (Arthritis), Vatha diseases, 
skin diseases, Leucorrhoea, Anuria, Dysuria, Abdominal pain, Kapha diseases, 
tuberculosis, Indigestion, Mukkkura Noi, Hicough, but the preparation varies for 
each disease.  
 Sangu parpam is one of the unique formulation to treat elumburuki and it 
may take long duration to control the disease. So it is necessary to assess its safety 
and toxicological effect for long duration with high dose. 
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AIM AND OBJECTIVES 
 
To assess the safety of „SANGU PARPAM‟ in short and long term 
administration through the animal experiment and to evaluate the toxicity of the 
drug.  
The „SANGU PARPAM‟ is an effective medicine to cure the disease 
elumburuki. 
But the adverse effects of these drugs are not ruled out so far, even though a 
long period of experience by the Indian medicine practioners had been obtained 
with this drug.  
 
OBJECTIVES 
 To study the acute toxicity of „SANGU PARPAM‟ in albino rats at 
100mg, 200mg, 400mg, 800 mg and 1600 mg per animal orally. 
 The study the chronic toxicity in albino rats at daily dose of 100 mg / 
100 gm body weight of animal and 200 gm / 100gm body weight of 
animal. 
 To study the systems affected by chronic oral administration of 
„SANGU PARPAM‟. 
  
5 
 
rq;F 
rq;F Ik;ngUk; jputpaq;fSs; xd;W vdr; rpwg;gpf;fg;gLfpwJ. tPuj;jpd; 
ngUikia tpsf;Fk; ntw;wpr; rpd;dkhfr; rq;F Koq;fpaij ehk; 
mwpNthk;. 
 mwptpay; mwpT mf;fhyj; jkpoHf;F mjpfkpy;iynad;W 
nrhy;gtHfs; $w;Wf;F khwhff; Fwpg;ghff; flypay; Jiwapy; - fly;gL 
nry;tq;fisg; gw;wpa jkpoHfspd;$He;j mwptpay; tpaf;fj; jFe;j 
tifapy; cs;sJ. 
 ,aw;ifahfNt ekf;Ff; fpilf;Fk; %yg;nghUSf;Fj; jputpak; 
vd;W ngaH. jkpoHfs; ,aw;ifg; nghUs;fisf; fly;gL jputpak;> fhLgL 
jputpak;> ehLgL jputpak;> kiygL jputpak; vd;W mt;tg;gFjpapy; 
fpilj;jpLk; rpwg;ghd nghUl;fis tifg;gLj;jpg; gphpj;Js;sdH. 
 Ik;ngUk; jputpaq;fnsdr; rpwg;gpf;fg;gLgit:- 
   rq;F (conch) 
   Kj;J (Pearl) 
   gtsk; (Coral), 
   cg;G (Salt) 
   xf;Nfhiy (Amber) 
  ,it fly;gL jputpaq;fspy; tifg;gLj;jg;gl;Ls;sd.  
 ,g;G+Tyfpy; %d;wpy; ,U gFjpiaf; nfhz;bUf;Fk; fly;> ekf;Fj; 
jUk; nry;tq;fs; fzf;fpylq;fh. vdpDk;> rpytifg; nghUl;fs;> ek; 
ehl;Lf;F ngUk; GfioAk;> rpwg;igAk;> me;epar; nrythzpiaAk; <l;bj; 
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jUtdthf mikfpd;wd.Fwpg;ghf Mo;flypy; %o;fp rq;F vLj;jiyAk;> 
Kj;Jf; Fspj;jiyAk; ek; jkpof kf;fs; gy E}W Mz;LfSf;F Kd;dNu 
mwpe;J mjd;top ngUikg; ngw;wtHfshthHfs;. cyfpNyNa 
Kj;Jf;fisAk;> rq;FfisAk; gw;wp Kjd;Kjyhf mwpe;jtHfs; jkpoHfs; 
vdpy; mJ kpifad;W. Mrpag; gFjpapNyNa> Fwpg;ghf ,e;jpahtpy;> 
mjpYk; Fwpg;ghfj; jkpofj;jpy; kl;LNk rpwg;ghff; fpilf;ff;$ba ‘rq;F” 
tiffis kf;fs; Gdpjg; nghUshfTk;> G+irg; nghUshfTk;> kUe;Jg; 
nghUshfTk; gad;gLj;jp tUfpd;wdH. rq;fpd; ePH ghtj;ij ePf;f ty;yJ 
mjpy; itf;fg;gLk; ghy; re;jjpaw;w ngz;fSf;F Gj;jpug; Ngw;iw 
mspf;fty;yJ. 
 kdpjd; jd; Foe;ijg; gUtj;jpy; rq;Fg; ghyhilapy; ghy; 
mUe;Jtjpy; njhlq;fp> mtDila ,Wjp ahj;jpiuapy; rq;nfhypf;f 
mlq;FtJ tiu> mtdJ tho;tpd; gy epiyfspy; ‘rq;F xU rhpj;jpuk;” 
gilj;jpUf;fpwnjdpy; mJ kpifapy;iy. ‘rq;F” ek; jkpofj;jpy; kl;LNk 
kpf mjpf mstpy; fpilf;ff;$ba fly;gL nghUshFk;. 
NtW ngaHfs;:- 
 fk;G> NfhL> rq;F> rq;fk;> Rj;jp> RhpKfk;> ee;J> ehF> Njtjj;jk;> 
gzpyk;> ,lk;Ghp> tyk;Ghp> tis> nts;is> juh> tz;L> thuzk;. 
kUj;Jt epfz;Lfspy; $wg;gl;Ls;s rq;fpd; gy;NtW ngaHfs;:- 
 rl;lKdp epfz;L – fz;lfr; rq;F> ftnuO rq;fk;> cad;w  
Ntyr;rq;F> cNuhkj;jpd; rq;F. 
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NghfH epfz;L – 1200 
  jtsk;> jpilehjk;> tis> thUjpdhjk;> tyk;Ghp> ,lk;Ghp> 
rpd;dk;> gzpyk;> ryk;Ghp> gl;rp> fk;G> ryQ;ryk;> ePq;fhj NthirNahd; 
  ‘rq;fpDlNgHjidNa rhw;wf; NfS 
   jts khe;jprdhjk; tisakhLk; 
  tq;fpdpl tyk;Ghpahkplk; GhpAkhFk; 
   thUjpap dhje;jhd; rpd;dkhFk; 
  eq;fpdpl rq;fhFk; gzpyk; ghzp 
   eykhd ryk;GhpAk; gl;rpfk;G 
  rq;fpdpl ePq;fhj Nthir Nahdhk; 
   ryQ;rykhQ; rq;fpdpl ehk khNk”. 
 kq;fskakhd ,d;gj;ij tpUk;Gfpd;wtHfSf;F tpUk;gpaijf; 
nfhLg;gjhy; ‘fk;G” vd;Dk; ngaH ngw;wJ vd;gH. rq;F fly;tho; 
caphpdnkd;gjhy; ‘[Ptd;” vd;w ngaUk; tlnkhopapy; cz;L. 
 rq;Ffspd; rpwe;j tiffisf; Fwpg;gpLk;NghJ> jkpo; epfz;LfSk;> 
tlnkhop E}y;fSk; mtw;iw ,lk;Ghp> tyk;Ghp> ryQ;ryk;> ghQ;rrd;dpak; 
vd;W ehy;tifg;gLj;jpAs;sd.  
  ‘,g;gp MapuQ; #o;e;jJ xU ,lk;Ghpnad;Wk;> 
   ,lk;Ghp MapuQ; #o;e;jJ xU tyk;Ghpnad;Wk;> 
   tyk;Ghp MapuQ; #o;e;jJ xU ryQ;ryk; vd;Wk;> 
   ryQ;ryk; MapuQ; #o;e;jJ xU ghQ;rrd;dpak;” 
vd;Wk; $wg;gLfpd;wJ. 
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rq;fpd; tiffs;:  
1. ryQ;ryk; (XH rq;F)> a conch shell of super eminent quantities 
volute ryrum. 
2. Kl;rq;F – Prickly chank one with thorn like points. 
3. gl;b my;yJ rpW rq;F 
4. Fw;rq;F> Chank containing or Impregnated with pearls. 
5. jhoQ; rq;F> One with a wide mouth 
6. tyk;Ghp rq;F> One with spiral opening to the right, chank shell of 
happy convolutions (topghl;bw;Fhpa cd;djg; nghUs; MAs;> 
nry;tk;> kf;fl;NgW ngUFk;. 
7. ,lk;Ghpr; rq;F – Ordinary chank with an opening to the left  
8. ghyhilr; rq;F – small conch used for giving milk to children.  
9. ctHr;rq;F (same as 2) 
10. ePh;tho; rq;F> conch shell turbinella raps 
11. Ks;Sr; rq;F 
12. ghw;rq;F> white chank 
13. ntz; rq;F 
14. gr;ir rq;F 
15. CJ rq;F 
16. fpU\;z rq;F the conch worn by vishnu.  
17. jPHj;j rq;F> sacred conch shell  
18. thpr; rq;F> striped conch 
19. ghQ;r rd;dpak;> XH tpj rq;F 
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20. njhzpr; rq;F 
21. flw; rq;F> a large convolute shell regarded as religious. 
22. fz;lfr; rq;F> a thorny chank in the sacred Gandhaka river near 
Banaras.  
23. Nfhyrr;rq;F.  
nra;if:  
 cly; cukhf;fp> Jaulf;fp> mfl;L thAtfw;wp> grpj;jPj;J}z;b> 
JtHg;gp> ntg;gfw;wp> Nfhioafw;wp.  
nghJFzk;:  
 ‘frpth kpuj;j gpj;jq; fz;Nzhaf NsFk; 
  grpahWk; thjk; gwf;F - kprpTlNd 
  jq;F Kis tpuze; jhdfY Nknts;isr;  
 rq;fkJ Tz;lhapw;whd;” 
ntz;rq;fpdhy; ,uj;j gpj;jk;> fz;Nzha;fs;> thj kpFjp> ,rpT> 
Kisf;fl;b Kjypad ePq;Fk;> grp cz;lhFk;. 
Rj;jp: 
 xU nghUspy; cs;s er;R jd;ikia ePf;fp mij kUe;jhfTk;> 
clypy; nrd;W NrHtjw;F VJthfTk; nra;tJ Rj;jpahFk;. 
rq;F Rj;jp: 
 xU gyk; rq;fpw;F 5 gyk; ,iyf; fs;spr; rhw;iwf; fhiyapy; tpl;L 
khiy tiu nta;apypy; cyHj;jp> kWehs; fhiyapYk; Gjpjhf Nkw;gb 
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rhw;iw tpl;L nta;apypy; itf;fTk;. ,q;qdk; NkYk; %d;W Kiw nra;J 
ePH tpl;L fOtpnaLf;fr; Rj;jpahFk;.  
gpw Rj;jp Kiwfs;: 
1. Kl;rq;ifg; gUkdhd Jz;Lfshfr; nra;J jz;zPhpy; my;yJ 
,sePhpy; MWkzp Neuk; Cw itj;Jr; nrk;ikahf myrp mjpYs;s 
kz; Kjypaitfis ePf;fp tpLtNj Rj;jpahFk;.  
2. fw;Rz;zhk;Gk; ctHkz;Zk; rkntil $l;b> vz;klq;F ePH 
NrHj;Jj; njspntLj;J> mjpy; rq;ifg; Nghl;L vhpj;Jf; fOtp vLf;f 
Rj;jpahFk;. 
3. rq;if fw;Rz;zhk;gpy; Gijj;Jj; jhspj;J fOtp vLf;f Rj;jpahFk;. 
 
rq;F NrUk; gpw kUe;Jfs; 
1. rq;F gw;gk; 
Njitahd ruf;Ffs;: 
 ntz; rq;F „ 1 fpNyh 
 vYkpr;rk; gor;rhW   nry;yj;jf;f msT 
 Mfhrj; jhkiuapiy rhW  
 Mfhrj; jhkiu r%yk; - 5 fpNyh 
nra;Kiw:  
 ntz;rq;Ffis cilj;J> gor;rhw;wpy; %o;fg; Nghl;L 4 ehl;fSf;F 
Cw tpl;Lg; gpd; nfhjpf;f itj;J Mwpa gpwF fOtp> 5 fpNyh Mfhrj; 
jhkiuia miuj;J Kd; Rj;jg;gLj;jpd rq;Ffis eltpy; ed;FyHj;jp 
100 vUtpy; GlkplTk;. Mwpagpd; cs;spUf;Fk; rq;Ffisf; ftdkhf 
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vLj;J Mfhrj; jhkiur; rhWtpl;L miuj;J tpy;iy jl;b> cyHj;jp> 
mfypy; Nghl;L Nky; mfy;%b rPiy kz; nra;J 100 vUtpy; Glkpl;L 
vLf;f rpwe;j gw;gkhFk;. 
msT:  
 200 kp.fp. tPjk; jpdk; ,UNtis> xU kz;lyk;.  
Jiz kUe;J: 
 nea;> ntz;nza;> ghy; 
jPUk; Neha;fs;: 
 Fd;kk;> #iy> rHk Neha;fs;> tapw;Wf; NfhshWfs;> cl;#L> 
%j;jpuf;fphpr;ruk;> rpWePH kQ;rs;> ePnuhpr;ry; 
 
2. rq;F Rz;zk; 
 ngUk; rq;iff; fy;Yuypy; ,bj;J Jzpapy; tbfl;b vYkpr;rk; 
gor;rhw;iw tpl;L xU rhkk; Neukiuj;J tpy;iy nra;J ed;wha; cyHj;jp 
mfypy; itj;J NkNyhL %b ,uz;L rPiy kz; nra;J ftrj;jpd; 
vilf;F 20 gq;F vil twl;bapy; Glkpl;L Mwpa gpd; vLf;fg;gl;l 
rq;fhdJ Rz;zkhfp ,Uf;Fk;. ,jpy; Nkw;fz;l vil epWj;J vLj;Jf; 
nfhs;s Ntz;baJ.  
 Rz;zj;ij jdpahfNt cgNahfpf;fyhk;> ,jw;F ghz;L> ePHf;fl;L> 
ePHf;Nfhit> kQ;rs; Neha; Mfpait jPUk;. 
 
3. rq;F nre;J}uk; 
 rq;if> nts;is Ntisr; rhW> fw;whior; rhW ,uz;ilAk; 
nfhz;L jdpj; jdpaha; miuj;J> Kiwg;gb Glkpl;nlLf;fr; nre;J}ukhk;.  
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 nre;J}uj;jpdhy; jPUk; Neha;fSk; Jiz kUe;JfSk;. 
Jiz kUe;J jPUk; Neha;fs; 
nts;is Ntisr; rhW cl;lz Nkfk; 
re;jdf; Fok;G thjk; 
cs;spurk; RNtj re;jp> gpj;j Neha; 
rhk;gpuhzpapiyr; rhW tPf;fghz;L 
vYkpr;rk; gourk; ntz;Fl;lk; 
nty;yk; Fd;k kJ Nkfk; 
ehty; gourk; &gtpfhuj; Njky;> Nkfk; 
,ytq;fg;gl;ilr; rhW re;epNjhlf; FspHik 
 
4. re;jpNuhja khj;jpiu 
 Rj;jp nra;j rq;F 2 ½ gyk;> ,jid xU tuhl;bapd; kPJ gug;gp 
itj;J mjd; kPJ xU tul;bia itj;J 100 gyk; tul;bapw; Glkpl;L 
Mwpd gpd;ndLj;Jf; nfhs;sTk; ,g;gbr; nra;tjhy; rq;F miu 
Ntf;fhlhapUf;Fk;. KO Ntf;fhlhf Ntz;Lnkd;gJ mtrpakpy;iy. 
$Lkhdhy; NtW ve;j tpjkhfpYk; rq;if miu Ntf;fhlhf Rl;Lf; 
nfhs;s Ntz;baJ. ,t;tpjk; miuNtf;fhlhfr; rl;l rq;F gq;F – 1 
J}a;ik nra;J cyHj;jpa nghhpj;Jg; nghbj;j ehl;L ntz;fhuj; J}s; gq;F 
– 1/4 > Kiyg;ghy; nry;yj;jf;f msT.  
nra;Kiw: 
 Kd; fz;l %d;W ruf;FfisAk; fy;tj;jpypl;L Kiyg; ghiyr; 
rpWfr; rpWf thHj;J xU rhkk; miuj;J xU Fd;wpkzp vil msT 
khj;jpiufs; nra;J epoypYyHj;jp itj;Jf; nfhs;sTk;. 
msT:  
 1 Kjy; 2 khj;jpiu 
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Jiz kUj;J: 
 Kiyg;ghy;> Njd;> gd;dPH> frfrhf; FbePH. 
jPUk; Neha;fs;: 
 Ruk;> ,Uky;> Foe;ijfspd; Neha;> gpj;j rk;ge;jkhd Neha;. 
 
5. vypf; fbf;Ff; Nfhlf rhiy vz;nza; 
rq;F tp\;Zfpue;jp 
Nfhlf rhiy Nfhit 
tPop NtH nre;ehAUtp NtH 
ifahe;jfiu Gq;fk; NtH 
fhl;L ky;ypif  ntl;ghiy ,iy 
,Yg;ig NtH nts;Nty; 
%f;ful;il NtH jpUFfs;sp NtH 
mKf;fpuhf; fpoq;F nehr;rpNtH 
fw;#iu NtH kpsfuiz NtH 
gpuz;il NtH  tpsh 
nfhd;idg; gl;il cfhNtH 
jpg;gpyp tpy;tg;gj;jphp 
G+z;L Nfh\;lk; 
nrq;fOePHf;fpoq;F fLf;fha;j; Njhy; 
rPufk;  
 
 ,itfis tiff;F1 tuhf ndil (4.2fpuhk;) tPjnkLj;J ed;whf 
,bj;J ey;nyz;nzAld; (3 NrH / 8.40 fpuhk;) fye;J mLg;gpd; NkNyw;wp 
vhpj;Jr; rpte;j gjj;jpy; ,wf;fp tbf;fTk;. 
 ,e;j vz;nzapy; xU Jl;nlil naLj;J cl;nfhs;sTk;. vyp 
fbj;jdhNyw;gl;l tp\q;fs; jPUk;. 
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6. ead Nuhfj;jpw;F khj;jpiu 
fly; Eiu 
rq;F (Rl;lJ) 
Nrhop (Rl;lJ) 
kpsF  
Njw;whd; tpj;J (rPtpaJ) 
 ,itfisr; rkkhf vLj;Jg; Nga;f;fUg;gQ; rhw;wpdhyiuj;J 
khj;jpiuahfj; jpul;b> epoypYHj;jp Kiyg; ghypypioj;J fz;zpypl 20 
tUlq;fs; nrd;w G+Tk; khWk;. 
ey;y rq;F fz;lwpa  
 rq;fpid xU fpzw;W ePH epiwj;j ghj;jpuj;jpypl;L 5 ehl;fs; 
mkpo;j;jp itj;jpUf;f Ntz;Lk;.  
 Rj;j rq;fhapd; epwk; khwh 
 NtW rq;fhapd; fUj;J ntbg;G Vw;gLk;. 
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fw;whio 
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fw;whio 
NtW ngaH : - fd;dp> Fkhp 
,/J ,e;jpah Kw;wpYk; Mw;wq;fiufspYk; rJg;G epyq;fspYk;> 
Njhl;lq;fspYk; gapuhFk;.  
 ,J rpWfw;whio> ngUq;fw;whio> Nga;f;fw;whio> fUq;fw;whio> 
nrq;fw;whio vdg; gytifg;gbDk;> ,jd; nra;if Kjypad 
rw;Nwwf;Fiwa xj;NjapUf;Fk;. 
 rptg;G tif fpilg;gjhpJ. ,jd; ngUikia NghfH> Vohq; 
fhz;lj;jpy; fhz;f.  
 gad;gLk; cWg;G - ghy;> klw;NrhW> rhW> NtH. 
 Rit - rpW ifg;G  
jd;ik – jl;gk;   
gphpT - ,dpg;G. 
nra;if:  
 cukhf;fp  
 clw;Nww;wp 
 ePHkyk;Nghf;fp 
 UJcz;lhf;fp 
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  tw;whf; Fkhpjd;id tw;wnyd Tz;zpDQ;rPH 
  Kw;whf; Fkhpnad %@Nk – ew;whf;Fe;  
  jpz;ikA ky;yhj; njhpitaNkahdhY 
  Kz;ikkpF E}whkh As;.    (Njud; ntz;gh) 
 fw;whioia cyHj;jp Kiwg;gb nghbahfr; nra;J cz;zpy; 
vg;nghOJk; ,sikahf td;ikAld; E}whz;L thoyhk;.  
fw;whio tw;wy; 
 Fkhpapd; tw;wYk; nfhsg;gpzp afYk;  (NjiuaH fhg;gpak;) 
 (nghUs;): fw;whio tw;wy; gpzpiaf; fz;bf;Fk;.  
Nga;f;fw;whio> nrq;fw;whio 
 Nga;f;fw;whiof;F kpFePUk;> cly; vhpTk;> RuKk;> nrq;fw;whiof;F 
cs;soiyAk; Nghk;. ,jdhy; ,Uk;G jq;fkhFk;. 
  Nga;fw;wh iof;Fg; ngUNkfk; nka;nahpr;ry; 
  Va;f;ff;$ lhmoYk; VFq;fhz; - jha;f;Fepf 
  uhQ;rpte;j fw;whio aq;fq; FspHtpf;Fk; 
  gha;Q;raj;ijg; nghd;dhf;Fk; ghH.  (mfj;jpaH Fzthflk;) 
fw;whioapd; Nrhw;iw vLj;Jg; gy Kiw fOtp> ,jpy; rpwpJ gbfhuk; 
my;yJ rPdhfw;fz;L NrHj;J> rpW Jz;by; Kbe;J njhq;ftpl mjpy; ePH 
tbAk;. ,ijf; fz;fspy; tpl> fz;Nzha; fz;rptg;G> fz;zUfy; 
Kjypad khWk;. 
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nghJ  
Fzk;: ,jdhy;> thjNkfk;> fUNkfk;> fpUkpf;Fj;jy;> ngU tpahjp> 
%yk;> cd;khjk;> gfe;juk;> Fd;kk;> gpj;jf;fphpr;ruk; ,it Nghk;.  
 nghy;yhNk fq;fgk;G Or;#iy Fl;lurk;  
 my;yhHkj; jk;gfe;j uq;Fd;kk; vy;yhk;tpl; 
 NlF khpf;F nkhpr;rw; fphpr;ruK 
 khF khpf;F kUz;L.    (NjiuaH Fzthflk;) 
 ,sklYld;> rPufk;> fw;fz;L NrHj;jiuj;J> FUjpAk; rPjKk; fye;j 
fopr;rYf;Ff; nfhLf;fyhk;: kQ;rs; rpwpJ NrHj;J miuj;J> Muk;g 
gpyPf tsHr;rpf;F> fhy; my;yJ miug;gyk; tiuapy;; nfhLf;fyhk;.  
 ,jd; rhw;iwf; nfhz;L vz;nza;> ,Nyfpak; Kjypad nra;J 
Nkw;$wpa Neha;fSf;Ff; nfhLf;fyhk;.  
 ,jd; rhw;iw> ntg;gj;ijj; jzpg;gjw;fhFk; gw;gr; 
nre;J}uq;fSf;Fj; JizahfTk; nfhs;syhk;.  
 ,e;jr; rhw;iw ntJg;gp khe;j Neha;fSf;Fk;> Copahy; fhZk; 
ePHNtl;iff;Fk; nfhLf;fyhk;. jhgpjq;fSf;Fk;> tPf;fq;fSf;Fk; G+r> 
mit jzpAk;> rpwpJ mgpdp NrHj;Jj; jiyf;Fg; gw;wplj; jiy Neha; 
ePq;Fk;. ey;nyz;nza; xnuilahff; fye;J fha;r;rpj; jiyapy; 
jltptu> J}f;fk; cz;lhFk;. 
 ntz;nza;> fw;fz;L> thy;kpsFj;J}s; ,itfisr; rhw;Wld; 
NrHj;Jz;z ePHr;RUf;F> clyhpg;G> cs;ntl;if ePq;Fk;. 
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NrhW 
Nrhw;iw vLj;J vz;nzapypl;Lf; fha;r;rpj; jiyf;Fj; Nja;j;Jj; 
jiy KOfptu> kapH tsUk;. epj;jpiu cz;lhFk;.  
rpw;whkzf;nfz;nza; 340 fpuhkpy;> fw;whior; NrhW 85 fpuhk; 
Cwitj;J miuj;J> nte;jak; 8 1/2 fpuhk;> rpWf mhpe;j nts;is 
ntq;fhak; 1> NrHj;Jf; fha;r;rpg; gjj;jpy; ,wf;fp tbfl;b> mijf; 
fhiyapyhfpYk;> ,utpy; gLf;iff;Fg; NghFKd;duhfpYk; XH 
cr;rpf;fuz;b rhg;gpl;Ltu> clw;#L ePq;Fk;. cly; ngUFk;. Nkf mdy; 
khWk;.  
ghy; 
,ij fz;> ,iug;igapy; cz;lhFk; Gz;fSf;Fj; jltyhk;. 
,Uk;G my;yJ v/F ,jdhy; ePwhFk;.  
fhpaNghsk; 
NtW ngaH : - %rhk;guk;> rd;dprhafk;> ,uj;jNghsk;  
Eng.   Small Aloe. later of Indian Aives  
Tel.  Chinikalabanda 
Mal.   Chenni Nayakam  
Sans.  Ikshurmalika 
Kan.   Lolisara 
Hind.  Chhotakanvar 
 
fhpaNghsk; vd;gJ rpW fw;whioapd; cyHe;j ghy;>  
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,J fUg;ghfTk; rptg;ghfTk; ,Uf;Fk;.  
,J njd;fiu Nahuj;jpy; (fd;dpahFkhpapy;) ,aw;ifahfj; 
Njhd;wpg; gapuhFk;. ,jdhy;> ,jw;Ff; “fd;dp” vd;Wk;> ‘Fkhp” vd;Wk;> 
,jd; ghYf;F ‘fd;dpahrhuk;”> ‘fhpaNghsk;” vd;Wk; ngaHfs; 
toq;fg;gLk;.  
,J> fw;whio ,dj;ijr; NrHe;j rpy nrbfspypUe;J vLj;J> 
cyuitj;Jf; nfhs;SfpwjhfTk; fUjg;gLfpwJ.  
Nky;ehl;lhH kUe;jpy;> ehY tiff; fhpaNghsk; cz;L. mit:  
1. nrhf;Nfhl;iud; Soccotrine 
2. n`g;ghl;bf;  Hepatic 
3. ghHg;Nlh];  Barbadoes. 
4. Nfg; MNyh];   Cape Aloes. 
,itfs; epwj;jpy; NtWgLNkad;wp nra;ifapy; xd;Nw.  
Rit – ifg;G  
jd;ik – ntg;gk; 
gphpT – fhHg;G  
nra;if:  
 cukhf;fp 
 ntg;gKz;lhf;fp 
 grpj;jPj;J}z;b 
 ngUq;fopr;rYz;lhf;fp 
 UJTz;lhf;fp 
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Fzk;:  
,J> khHGtyp> tPf;fk;> tapw;Wtyp> gf;fNeha;> Nkff;fl;b> 
iffhy;fspy; cz;lhfp epiyj;j #iy> ngUtsp Neha;fs; ,itfisg; 
Nghf;Fk; 
 khHGtyp tPf;fk; tapw;Wtyp gf;fNeha; 
 thHNkff; fl;bnahL khthjk; - ghUyfpy; 
 ePsq;if fhypy; epiy#iy Aq;fWj;j 
 Nghse; jidf;fhzpw; Nghk;.   (mfj;jpaH Fzthflk;) 
msT: ,ij 130 kp.fp. Kjy; 190 kp.fp. vil tiu 2>3 ehl;fSf;F 
xU Kiwahf nfhLf;f> grpj;jPiaj; J}z;Lk;. 
 325 kp.fp. Kjy; 650 kp.fp. vil nfhLf;ff; fopr;rYz;lhFk;.  
 ,jpy; ifg;Gk; nfl;lehw;wKkpUg;gjhy;> jdpNa nfhLf;fhky;> 
NtW kUe;JfNshL NrHj;Jf; nfhLg;ghHfs;.  
 NkYk;> ,J ngUq;FlypYk; fPo;thapYk; Ngha;g; gutp 
ntg;gKz;lhf;Fk; jd;ikAs;sjhifahy; #iyf; fiuf;Fk;. 
Mjypd;> #y; nfhz;l ngz;fl;Ff; nfhLf;Fq;fhy; mstwpe;J 
nfhLj;jy; Ntz;Lk;.  
 Nkw;fz;l Neha;fsy;yhky;> ke;jk;> kQ;rs;fhkhiy> #jff;fl;L> 
Mfpa ,itfisAk; Nghf;Fk;.  
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fhpaNghs khj;jpiu 
%rhk;gur; #uzk;  - 56 fpuhk; 
rTf;fhuj; J}s;  - 28 fpuhk; 
rhjpf;fha; vz;nza; - 4 fpuhk; 
Fy;fe;J   - 28 fpuhk;.  
,tw;iw xd;Wgl miuj;J 325 kp.fp. – 650 kp.fp. jpdk; ,UNtis 
nfhLf;f> ,J Nkw;$wpa tpahjpfisf; fz;bf;Fk;.  
fha%rhk;gu khj;jpiu 
%rhk;guj;J}s; - 1 gq;F 
ngUq;fhak;  - 1 gq;F 
rTf;fhuj;J}s; - 1 gq;F 
Fy;fe;J  - 1 gq;F 
 ,tw;iw xd;Wgl miuj;J 325 kp.fp. – 650 kp.fp. nfhLf;f> 
#jfj;jpy; fhZk; tapw;Wtyp epw;Fk;. tapW fopAk;.  
 nrbapd; Ntiuf; FbePhpl;Lf; nfhLf;f> RuNeha; Nghk;. ,J 
kyf;fl;il ePf;Fk;. jPl;il cz;lhf;Fk;.  
 filapw; fpilg;gjpy; kz;> fy;> J}R fye;jpUg;gjhy;> ,ij 
toq;FKd; nte;ePhpypl;Lf; fiuj;J> xU ehs; nrd;w gpwF 
tbfl;b nta;apypy; itj;J ed;wha; ,Wfpagpd; vLj;J toq;fTk;.  
 xd;wiu Kjy; %d;W Fd;wp vil nfhLf;f> tapW fopAk;.  
 fhpaNghsk; 780kp.fp.> md;dNgjp 1>950 kp.fp. ,t;tpuz;ilAk; 
NghJkhd msT Njd; tpl;L miuj;J> miuf;fhy; tuhfndil 
tPjk;> ehnshd;Wf;F %d;W juk; nfhLf;f> ngz;fSf;F NehpLk; 
FUjpr; rpf;fiy mWj;J ntspg;gLj;Jk;.  
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 fhpaNghsk; 650 kp.fp. md;dNgjp ,tw;iwg; NghJkhd msT 
Njd; tpl;Lr; NrHj;jiuj;J> xU thu kl;Lk; 130 kp.fp. tPjk; MW 
kzpf;nfhU KiwAk;> ,uz;lhk; thuj;jpy; ehnshd;Wf;F 
,UKiwAk;> %d;whk; thuk; Kjy; ehnshd;Wf;F xU KiwAk; 
czTf;Fg; gpwF nfhLj;Jtu ehl;gl;l vUf;fl;L ePq;Fk;.  
 fhpaNghsk; 680 kp.fp.> fhak; 650 kp.fp. ,t;tpuz;ilAk; 
nfhs;sj;jf;f msT Njd; tpl;L miuj;J> 130 kp.fp. vil 
khj;jpiu nra;J ehnshd;Wf;F ,uz;L juk; nfhLf;f> 
nrhpahik> ke;jk;> #jf tapw;Wtyp ePq;Fk;.  
fw;whio NrUk; gpw kUe;Jfs; 
1. rpj;j taputk; 
 jPUk; Neha; - rpk;kf rd;dp 
2. gr;ir fw;G+u khj;jpiu 
 gr;irf; fw;G+uk;> ytq;fk;> rhjpf;fha;> ,urg;gjq;fk;> fe;jfk;> thsk; 
tiff;F> gyk; Kiwg;gb Rj;jpj;J> fy;tj;jpypl;Lg; nghbj;J> fw;whio 
ePhpdhy; gf;Ftk; tUkl;lk; miuj;J cse;jsT khj;jpiufs; nra;J> 
epoypYtHj;jTk;> Njd;> ,Q;rpr; rhW ,itfspy; Ntisf;F xU 
khj;jpiuahff; nfhLf;f> ntg;Gr; Ruk;> jhgr; Ruk;> thjk; - 80> gpj;jk; - 40> 
Nrj;Jkk; - 96k; jPUk;.  
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3. G+kzp khj;jpiu 
 NeHthsk; 2 gq;F> fLfNuhfzp 1 gq;F. ,Yg;igg;G+ 1 gq;F. 
,itfis Kiwg;gb Rj;jpj;Jf; fy;tj;jpl;Lg; nghbj;Jf; fw;whior; 
rhw;why; ehd;F rhkk; miuj;J> J}Jsq;fha; msT khj;jpiufs; nra;J> 
epoypy; cyHj;jTk;. ,k; khj;jpiu xd;W my;yJ ,uz;L> Njd; 
,Q;rpr;rhw;Wld; $l;bf; fhiyapy; nfhLf;f> kyq;fopjYld;> Ruk;> rd;dp> 
tplhr;Ruk; jPUk;. nts;isg; G+z;bd; ijyj;jpy; nfhLf;f 7 Njh\q;fSk; 
jPUk;. Kj;njz;nzapy; <a tha;Tfs; jPUk;. 
4. G+uz re;jpNuhjak; 
  msT  - gawsT  
 Jiz kUe;J  - ntz;nza;> rHf;fiu> ,Q;rpr; rhW. 
 jPUk; Neha;fs; - $bak;> vl;L tiu Fdkq;fs;> Rthrfhrk;> 
ghz;L> Nrhig> 13 tif rd;dpfs;> 
,e;jphpa e\;lk;. 
5. Fq;fpypa gw;gk;: 
 kl;il Nghf;fhj ,sePhpd; Nkw;Gwj;ijr; rPtpj;J thukpl;L> mjpy; 
ntz; Fq;fpypaj;ijg; nghbj;Jr; nrYj;jp> xU thafd;w ghj;jpuj;jpy; 
Rj;jePH tpl;L> mjpy; Nkw;gb fha; Kf;fhy; jpl;lk; kiwAk; gb itj;J 
vhpf;fTk;. vhpf;Fk;NghJ xU Fr;rpnfhz;L Jthuj;jpy; nrYj;jpg; ghHf;ff; 
Fq;fpypak; cUfpapUe;jhy; mijnaLj;J> ,sePH mlq;fpa NtW xU 
ghj;jpuj;jpy; nfhl;b> Mwpd gpd;dH> mijnaLj;J Kd; NghyNt NkYk; 9 
- Kiw nra;J> Ez;zpa Jfshfg; nghbj;J itj;Jf; nfhs;sTk;. ,JNt 
KbT ngw;w gw;gk;. MapDk; ,ijf; NfhopKl;il ntz; fUtpNyDk;> 
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Nrhw;Wf; fw;whior; rhw;wpNyDk; miuj;J> Ff;fplg; Glkpl;Lk; 
cgNahfpf;fyhk;. 
cgNahfpf;Fk; msT:  
 xd;WKjy; ehd;F Fd;wp kzpasT> Neha;gyk;> Nehahsp gykwpe;J> 
rPjtPhpa %ypiffspy; xd;wpy; mDghdpj;Jf; nfhLf;f> ePH vhpr;ry;> 
ePHf;fl;L> gpuNkfk;> ntl;il Kjypad jPUk;. 
6. MWKf nre;J}uk; 
  msT  - ½ - 1 Fd;wp msT 
 Jiz kUe;J - jphpfLFj; J}s;> Njd; 
 jPUk; Neha;fs; - miuthjk;> tpiuthjk;> mWtif %yk;> 
vhpFd;kk;> twl;rp> mdy;> ntb#iy> khHGr;#iy> fHg;gNuhfk;> ghz;L> 
Nrhif> fpue;jp> Fly;thjk;> thjgpj;jk;> rak;> miuahg;G> kjk;> mjprhuk;> 
kz;ilapb> njhz;iltyp> fz;lkhiy> twl;#iy> #iy. 
7. Rakhf;fpdpr; nre;J}uk; 
  msT  - Fd;wpkzp msT 
 Jiz kUe;J - ,Q;rpr; rhW 
 jPUk; Neha;fs; - Fd;kk;> kNfhjuk;> ftpir> Kis%yk;>  
fpuhzp> Gspj;Njg;gk;> mz;lthjk;> rd;dp. 
8. ntz; G+rzpf; fpUjk; 
  msT  - nghl;Lf; fuz;b tPjk;> ,UNtis. 
 jPUk; Neha;fs; - nts;is> #L> vhpr;ry;> fhe;jy;> ePHf;Fj;J>  
Mz;> ngz; Fwp vhpT> vYk;G tpuzk;> 
ntl;il> gpj;jk;. 
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9. Fkhp ,Nyfpak; 
  msT  - ½ Njhyh> ,UNtis. 
 jPUk; Neha;fs; - Nkf rk;ge;jkhd c\;zk;> fzr; #L jPUk;.  
jhJ G\;b cz;lhFk;. ngz;fSf;F 
cgNahg;gLj;jf; fUg;ghrak; gyg;gl;L 
khjtplhapYz;lhd gyg;gy gpzpfs; 
ePq;fpr; re;jhd ghf;fpak; cz;lhFk;.  
10. Fkhpj; ijyk; 
 thuk; xU Kiw Nja;j;Jf; Fspf;f> Nkfr;#L> Nkfnyl;il> fpue;jp 
Kjypa Nuhfq;fs; jPUk;.  
 Nej;jpu Nuhfq;fs; ePq;fpf; fz; gpufhrpf;Fk;.  
 gj;jpak;: - md;W Gsp js;sp ,r;rh gj;jpak; nfhs;f. 
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Njd; 
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Njd; 
 NjdPf;fs; kuQ;nrb nfhbfspYs;s G+f;fspy; mike;jpUf;Fk; 
mkpHjj;ijg; gUfpj; jk; clypYs;s Njd;igapy; NrHj;Jf; nfhs;fpd;wd. 
mg;NghJ mg;igapypUf;Fk; mkpHjk; xU tpj khWjiy milfpd;wJ.  
 ,k;khw;wkile;j mg;nghUisj; NjdPf;fs; milapYs;s miwfspy; 
ckpo;e;J NrHj;J itf;fpd;wd. ,g;nghUSf;F Njd; vd;gJ ngaH.  
 Njdpy; clYf;F Njitahd ,dpg;Gr;rj;J> cNyhfr; rj;Jfs;> 
itl;lkpd; Nghd;w vy;yh rj;Jf;fSk; rpW rpW mstpy; 
nghUe;jpapUg;gjhf jw;fhy tpQ;Qhdpfs; fz;L gpbj;jpUf;fpd;whHfs;. 
 Njd; $l;bypUe;J vLj;j Gjpa Njd; ,dpg;ghAk;> njspthAk;> 
,skQ;rs; epwkhAkpUf;Fk;. G\;gq;fSf;F Vw;wthWk; fhy Njrj;jpw;F 
Vw;wthWk; Njdpd; kzk;> cUrp> Fzk; Kjypad NtWgLk;.  
 Njd; 12 ehopifapy; [Puzkhfp tpLfpd;wnjd;W $wg;gl;Ls;sJ. 
Njdpd; tiffs; 
1. kiyj;Njd; 
2. nfhk;Gj;Njd; 
3. kug;nghe;Jj;Njd; 
4. Gw;Wj;Njd; 
5. kidj;Njd; 
vdj; Njdpy; Ie;J tifAz;L. 
kidj;Njdpd; Fzk; 
 tPLfspy; fl;Lfpd;w Njdhy; Gz;> rpiyNahly;> fug;ghd;> 
Nej;jputpuzf;fpUkp> GOntl;L> fgfhrk;> fhrk; Kjypa gpzpfs; ePq;Fk;. 
grp cz;lhFk;. 
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Gw;Wj;Njdpd; Fzk; 
 Gw;wpy; fl;Lfpd;w Njd; Iak;> fhrk;> Rthrk;>the;jp> fz;Nzha;fs; 
Kjypatw;iw ePf;Fk;. 
kug;nghe;Jj; Njdpd; Fzk; 
 kug;nghe;Jj; Njdpdhy; grpAk;> ntg;gKk; cz;lhFk;. the;jp> 
mf;fpdp ke;jk;> gy tifg;gl;l tPf;fk;> mNuhrfk;> fhrk;> Rthrk;> \ak;> 
mjpJ}yk; Kjypa gpzpfs; ePq;Fk;.  
nfhk;Gj;Njdpd; Fzk; 
 nfhk;Gfspy; fl;Lfpd;w Njd; Kf;Fw;wk;> ciskhe;ij> mNuhrfk; 
Kjypa gpzpfis ePf;Fk;.  
kiyj;Njdpd; Fzk; 
 kiyj;Njdpdhy; fgfhrk;> Rthrk;> tpf;fy;> Ruk;> fz;tpuzk;> 
Njff;fLg;G Kjypa gpzpfs; ePq;Fk;. grpAk; njhdpAk; cz;lhFk;. ,J 
kUe;JfSf;F ew;Wiz kUe;jhFk;.  
Njdpd; nra;if 
 cs;soyhw;wp  
 kykpsf;fp 
 JtHg;gp 
 mOfyfw;wp 
 Nfhioafw;wp 
 Ngh\zfhhp 
 grpj;jPj;J}z;b 
 J}f;f Kz;lhf;fp 
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Njd; Rj;jp 
 filj;Njdpy; nkOF> GO> Kl;il> kfue;j nghb Kjypa 
kypdq;fspUf;Fkhifahy;> ,jid cgNahfpf;F Kd; ePH ,ae;jpuj;jpy; 
itj;Jf; fha;r;rp #lhapUf;Fk; NghNj> <uf;fk;gspj;Jzpapypl;L tbfl;bf; 
nfhs;s Ntz;Lk;. 
 Xl;ilr; Rl;Lj; Njdpy; Nghl;L Kwpj;J cgNahfpg;gJ tPl;L tof;fk;. 
cgNahfq;fs;: 
 Njidg; ghdk; nra;J te;jhy; fgg;gpzpfs; ePq;Fk; vd;gij ,wTsH 
mKijia ,wTsjhf;Fk;” vd;w NjiuaH fhpry; mbfshy; 
czuyhk;. 
 gw;gk;> nre;J}uk;> #uzk;> khj;jpiu> FbePH Nghd;witfSf;F Njd; 
xU rpwe;j Jiz kUe;jhFk;. ,/J mDghdg; nghUshtjd;wp> 
mtpo;jg; nghSkhfp> Njfj;ij ed;dpiyapy; itj;J thjk; Kjypa 
Kf;Fw;wq;fisAk; Nghf;Fk;. 
 cs;soyhw;wp nra;iff;fhf Njid #Ls;s ghHyp mhprpf; fQ;rpj; 
njspePUld; nfhLg;gJz;L. 
 ,Nyfpak;> ghzpjk;> nkOF> fl;L> fz;ik Nghd;w kUe;Jfs; 
nra;tjw;F Njd; gad;gLfpwJ.  
 Foe;ijfspd; ,UkYf;F Njd; ,uz;L mTd;]; (56 kpyp) tpshtpd 
fhb (m) vYkpr;rk; gourk; rkd; $l;b Fiwe;j mstpy; nfhLj;J 
tuj;jzpAk;. 
 jPr;Rl;lg;Gz;> nte;ePH gLtjpdhy; cz;lhFk; Gz;> tpuzk; 
Kjypatw;wpw;F Njd; Nghl;L tur; rPf;fpuj;jpy; MWk;.  
 kJNkf Nehapw;fhf toq;fg;gLk; kUe;JfSs; NjDk; xU Kf;fpag; 
nghUshf NrHf;fg;gl;bUf;fpd;wJ. 
 tha; nfhg;Gspf;f cgNahfpf;Fk; FbePHfSld; Njd; NrHg;gJz;L. 
,J Nfhioia ePf;Fk;.  
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CONCH SHELL 
 
 A large number of species of molluscs are found in India; they occur in the 
sea, in brackish and fresh waters and on land. Some of them are of considerable 
economic importance and fished for food, for the pearls they yield and for their 
shells utilized in various ways. Among these molluscs, chank (ven sangu) is the 
most important species. It has many significance, as it is widely used in Medical 
aspects. Fishing for chanks is peculiar to India.  
 One variety called Turbinella pyrum Lam (sangu) is seen in vast in 
Tamilnadu costal areas. Apart from Tamilnadu, this is also seen at the costal areas 
of Andaman, Srilanka and Gujarat. Elsewhere this species is not available, thus 
bringing up chank fishery to be an important custom of India.  
 
Chank Fisheries: -  
 In India, Chank Fishery is carried out at the following coasts.  
1. Tirunelveli (Tuticorin Fishery) 
2. Ramnad (Sivagangai Fishery)  
3. Karnetic Coast (South Arcot, Tanjore). 
4. Travancore. 
5. Kathiyavar. 
Of these, Tirunelveli Chank fishery is the only one that is carried on 
systematically and with a definite organization. This is being habitual as long as 
1,800 years. Those who goes for chank fishery, form various groups and go for 
fishing. In each boat atleast 5 – 6 persons used to go. They spend 3 – 4 hrs in a 
day. Within this stipulated time, one person try to fish approximately 25 times. If 
the circumstances are favourable for them, they fish for 50 times.  
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Classification:  
 Class  : Gastropoda 
 Family :  Turbinella. 
Zoological Name : Turbinella pyrum lam. 
Commercial Name :  Sacred chank, Conch shell. 
 Tamil Name : Sangu, Ven Sangu, Oothu Sangu. 
External appearance of Chank:- 
 It has a large, massive, elegant shell with a fine pear – shaped spire and a 
wide opening or mouth which is prolonged into a narrow spout.  
 Male chank measures about 57 – 60 mm in its diameter and female chank 
about 58 – 60 mm. So usually the chanks measuring minimum 64 mm are only 
picked.  
 Chank has an external lustrous yellowish brown horny layer and beneath it 
a thick layer, chiefly formed of calcium carbonate.  
Valampuri Chank:  
 Chanks are characterized by large shells with fine texture and are highly 
valued.  
 Normally, the chank shells are formed in a dextral spiral; Occasionally 
shells with a sinistral spiral are also formed. This peculiar type of chanks is called 
as “Valampuri chank”. 
 These have a high value and very rarely caught, almost one in a lakh.  
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Uses of Chanks 
In Medicine:- 
 The shells were used to cure many ailments in many countries for years 
together. It is somewhat difficult to ascertain the exact nature of the diseases for 
which native practioners employ this specific; custom appears to vary with 
different districts and even with different doctors living in the same town.  
a. A remedy for pimples and other skin troubles on the face and body.  
b. Internally given for acute form of dyspepsia (Gunmam).  
c. Shooting Pain and Inflammatory condition in the joints.  
d. In case of Rickets, chank ring powder ground in water is rubbed on the 
breasts.  
e. In case of Asthma, Cough and Consumption. 
f. Used in headache, general debility and eye diseases.  
Apart from the above medicinal uses, chanks are also made into Bangles, 
Bracelets, Rings etc. 
Chanks also play a role in marriages, deaths etc.  
These are some of the zoological aspects, medicinal values and customary uses 
of ancient people.  
Action: 
 Nutrient 
 Anodyne 
 Carminative 
 Stomachic 
 Astringent 
 Febrifuge 
 Expectorant. 
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Aloe Barbadensis 
   
*A healthy aloe plant* *A fair sized leaf* *Gel in cross section* 
   
*Cut along leaf edge* *Peel to expose gel* 
*Run knife under gel* 
*Or scoop out with spoon* 
  
*Hold gel in hand* *Pull gel upwards* 
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Aloe Barbadensis 
 
There are over 200 types of Aloe Vera plants, but only 4 are suitable for use in 
dietary supplements. Aloe Vera Barbadensis is by far the most superior and 
beneficial of the four. 
Scientific classification 
Kingdom: Plantae  
Clade: Angiosperms  
Clade: Monocots  
Order: Asparagales  
Family: Xanthorrhoeaceae  
Subfamily: Asphodeloideae  
Genus: Aloe  
Species: A. vera 
 
Other Names: -  
 Sanskrit - Kumarirasasambhava,  Ghrita -     Kumari 
 Bengali - Ghrita Kumari 
 Gujarat - Kunwar 
 Hindi  - Musabhar, Ghikanvar 
 Kanada - Kolasoare, Komarika, Maulisara. 
 Malayalam - Kattavazha 
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 Marati  - Korphad 
 Orissa  - Kumara, Mushaboro 
 Tamil  - Chirukattalai, Katralai 
 Telugu - Kalabanda. 
Description:  
 Macroscopic 
  Leaves large, succulent, subulate, sessile, 20 – 50 cm long & 5 – 10 
cm wide. Apex in the form of a sharp and acute spine. Both the surfaces are 
strongly cuticularized. Dried leaf juice dark chocolate brown to black in colour and 
of irregular masses. Odour, Characteristic; taste very bitter. 
Microscopic:  
 Thin walled, large pericyclic cells contain yellow fluid. The fluid under 
microscope shows crystals in the form of innumerable needles, varying in size and 
shape.  
CHEMICAL CONSTITUENTS:- 
 Major : Hydroxyanthraquinone derivatives (25 – 40%) viz., aloin (= 
barbaloin, a mixture of aloin a & B, the diastereoisomeric  10 – c glucosides of 
aloe – emodin arithroue and F – hydroxyaloin isomers.  
 Minor: Include aloe emodin, chryso – phenol; chromone derivatives viz., 
aloe – resin B (= aloesin, upto 30%) with its p – coumaryl derivatives aloeresius  A 
& C and the aglycone aloesone.  
 Indian aloes contain aloinosides as major constituents with only traces of 
aloin.  
Pharmacology:  
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 Cathartic action of the drug, limited to large intestine, is attributed to 
anthraquinone glycosides, chiefly aloin. Latter is not absorbed in upper gut, but 
hydrolysed to the active aglycone at the site of action in the colon, and rectum by 
intestinal bacteria. The anthrones irritate the mucus membrance, leading to an 
increase in the secretion of mucus, thus stimulating peristalsis. Also they induce an 
active secretion of water and electrolytes into the lumen of the gut and inhibit the 
absorption of electrolytes and water by the colon. 
SAFETY ASPECTS:- 
 Prolonged use may severely affect the electrolyte balance and loss of 
potassium may ultimately reduce the laxative action and disturb the cardiac rhythm 
in heart patients. Larger doses lead to accumulation of blood in pelvic region and 
reflux stimulation of uterine muscles and may bring about abortion or premature 
birth in late pregnancy. Toxic doses can also cause kidney damage. Active 
principles generally appear in the milk during lactation. Due to these reasons the 
drug is contraindicated in pregnancy, lactation, kidney complaints and irritable 
bowel conditions.  
DOSAGE:- 
 50  - 200mg of the drug in the powdered form at bed time (Total intake not 
exceeding a week).  
Ulcer Reduction 
As medications such as Aspirin can cause excess acid, people suffering 
from high blood pressure, atherosclerosis, or other cardio vascular problems, who 
are taking them, are susceptible to ulcers. Aloe Vera Barbadensis, when taken 
orally, has been shown to reduce the acid in the stomach which may help to 
alkalize stomach acid, lessening the chance of ulcer development. 
People have noticed when they have had a bout of acid reflux, after 
drinking aloe vera juice or eating the gel, they feel much better. It also may have a 
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beneficial effect because Aspirin and other drugs like Warfrine can knock out an 
enzyme called cox 1 needed to produce prostaglandin. Prostaglandin plays a part 
in thickening the lining of the stomach. If the production of  Prostaglandin is 
limited, our stomach lining will not be thick enough to stop the acid damaging the 
wall. 
To Strengthen Veins and Arteries 
Aloe Vera Barbadensis may strengthen your blood vessels and capillaries 
too. Pubmed published some preliminary findings on October 7th 2004, that 
showed how carboxypeptidase an ingredient in Aloe Vera, was the contributing 
factor that inactivated a compound called Bradykinin. Bradykinin is a group of 
proteins that dilate blood vessels. If too much is in the blood it can weaken blood 
vessel walls causing damage and in effect can cause leakage of substances into the 
blood or leakage of substances out. Also the report suggests that Aloe Vera 
Barbadensis may reduce drag in the capillaries because of its drag-reducing 
polymer compound – avDRP, and reference is made in the report about its 
antioxidant properties. This all could be very beneficial for your circulation. 
No known serious side effects 
A Daily amount of 6 oz may be needed to begin with, depending on your 
problem, for maximum effect, until the aloe has dealt with the root cause of the 
problem, then you can lower the dose to 1 or 2 oz on an empty stomach, the 
recommended norm.  
A powerful anti-inflammatory and a great immune booster 
Inflammation of the body has been linked to hypertension. Back in 2003, 
the results of a study conducted by researchers from Harvard Medical School and 
Brigham and Women‟s hospital was published in the Journal of the American 
Medical Association. The report showed that elevated levels of C-reactive protein 
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in the blood suggested inflammation and indicated for the first time that 
hypertension / high blood pressure could be an inflammatory disease. 
Dr. Sesso, who led the research, although positive that there is a connection 
with inflammation and hypertension, did not know exactly what mechanism 
triggered it. Further research and evaluation was still needed. 
Professor Grundy at the Centre of Human Nutrition shed further light on the 
subject by stating that metabolic factors, (a combination of conditions) aggravate 
and cause injury to the artery walls, contributing to further inflammation. Knowing 
inflammation has a connection with high blood pressure should be enough warning 
to alert and move you to action. 
Aloe Vera Barbadensis is a proven anti-inflammatory  
Anti-inflammatory drugs, although they work well by reducing a certain 
type of prostaglandin that causes inflammation, can have an underlying problem. 
The prostaglandin they break down is the same kind that helps protect the stomach 
from acid and as I mentioned above, excess acid can cause ulcers. It is quite a 
common occurrence that those who take anti-inflammatories usually end up having 
to take anti-ulcer drugs. 
The inflammation is a reaction of the immune system. It is a defence 
mechanism to protect the body and works effectively when healthy, and a healthy 
immune system is the life of the organism. But when weakened or under stress, it 
can react erratically to such things as allergens, toxins causing multi-chemical-
sensitivity-syndrome, overweight problems etc, those “metabolic factors” 
contribute to undue inflammation throughout the body. 
Aloe Vera Barbadensis is noted for its immune strengthening properties. 
Polysaccharides in the aloe may reduce immune sensitivity to chemicals 
introduced into our bodies by modulating the immune system so it doesn‟t 
overreact. 
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Honey 
Honey is a sweet food made by bees using nectar from flowers. The variety 
produced by honey bees (the genus Apis) is the one most commonly referenced. It 
is the type of honey collected by beekeepers and consumed by humans. Honey 
produced by other bees and insects has distinctly different properties. 
Honey bees transform nectar into honey by a process of regurgitation and 
evaporation. They store it as a primary food source in wax honeycombs inside the 
beehive. 
Honey gets its sweetness from the monosaccharides, fructose, and glucose, 
and has approximately the same relative sweetness as that of granulated sugar. It 
has attractive chemical properties for baking, and a distinctive flavor that leads 
some people to prefer it over sugar and other sweeteners. Most microorganisms do 
not grow in honey because of its low water activity of 0.6. However, honey 
sometimes contains dormant endospores of the bacterium Clostridium botulinum, 
which can be dangerous to infants, as the endospores can transform into toxin-
producing bacteria in the infant's immature intestinal tract, leading to illness and 
even death. 
Honey has a long history of human consumption, and is used in various 
foods and beverages as a sweetener and flavoring. It also has a role in religion and 
symbolism. Flavors of honey vary based on the nectar source, and various types 
and grades of honey are available. It is also used in various medicinal traditions to 
treat ailments. The study of pollens and spores in raw honey (melissopalynology) 
can determine floral sources of honey. Because bees carry an electrostatic charge, 
and can attract other particles, the same techniques of melissopalynology can be 
used in area environmental studies of radioactive particles, dust or particulate 
pollution. 
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Honey's natural sugars are dehydrated to prevent fermentation, with added 
enzymes to modify and transform their chemical composition and pH. Invertases 
and digestive acids hydrolyze sucrose to give the monosaccharides glucose and 
fructose. The invertase is one of these enzymes synthesized by the body of the 
insect. 
Honey bees transform saccharides into honey by a process of regurgitation, 
a number of times, until it is partially digested. The bees do the regurgitation and 
digestion as a group. After the last regurgitation, the aqueous solution is still high 
in water, so the process continues by evaporation of much of the water and 
enzymatic transformation. 
Honey is produced by bees as a food source. In cold weather or when fresh 
food sources are scarce, bees use their stored honey as their source of energy. By 
contriving for bee swarms to nest in artificial hives, people have been able to 
semidomesticate the insects, and harvest excess honey. In the hive (or in a wild 
nest), there are three types of bees: 
 a single female queen bee 
 a seasonally variable number of male drone bees to fertilize new queens 
 some 20,000 to 40,000 female worker bees. 
The worker bees raise larvae and collect the nectar that will become honey in 
the hive. Leaving the hive, they collect sugar-rich flower nectar and return. 
In the hive, the bees use their "honey stomachs" to ingest and regurgitate the 
nectar a number of times until it is partially digested. Invertase synthesized by the 
bees and digestive acids hydrolyze sucrose to give the same mixture of glucose 
and fructose. The bees work together as a group with the regurgitation and 
digestion until the product reaches a desired quality. It is then stored in honeycomb 
cells. After the final regurgitation, the honeycomb is left unsealed. However, the 
nectar is still high in both water content and natural yeasts, which, unchecked, 
would cause the sugars in the nectar to ferment. The process continues as bees 
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inside the hive fan their wings, creating a strong draft across the honeycomb, 
which enhances evaporation of much of the water from the nectar. This reduction 
in water content raises the sugar concentration and prevents fermentation. Ripe 
honey, as removed from the hive by a beekeeper, has a long shelf life, and will not 
ferment if properly sealed. 
Physical and chemical properties 
The physical properties of honey vary, depending on water content, the type 
of flora used to produce it (pasturage), temperature, and the proportion of the 
specific sugars it contains. Fresh honey is a supersaturated liquid, containing more 
sugar than the water can typically dissolve at ambient temperatures. At room 
temperature, honey is a supercooled liquid, in which the glucose will precipitate 
into solid granules. This forms a semisolid solution of precipitated glucose crystals 
in a solution of fructose and other ingredients. 
Acid content 
The average pH of honey is 3.9, but can range from 3.4 to 6.1. Honey 
contains many kinds of acids, both organic and amino. However, the different 
types and their amounts vary considerably, depending on the type of honey. These 
acids may be aromatic or aliphatic (non-aromatic). The aliphatic acids contribute 
greatly to the flavor of honey by interacting with the flavors of other ingredients. 
Gluconic acid, for instance, is a flavor enhancer. The aromatic acids, such as malic 
acid, come mostly from the flowers, adding to the aroma and taste of the honey. 
Honey can contain up to 18 of the 20 amino acids. However, amino acid 
content is almost negligible in honey, accounting for only 0.05–0.1% of the 
composition. The main amino acid is proline. Amino acids are derived almost 
solely from the bodies of the bees. 
Organic acids comprise most of the acids in honey, accounting for 0.17–
1.17% of the mixture. Gluconic acid is the most prevalent. Gluconic acid is formed 
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by the actions of an enzyme called glucose oxidase. Other organic acids are minor, 
consisting of formic, acetic, butyric, citric, lactic, malic, pyroglutamic, propionic, 
valeric, capronic, palmitic, and succinic, among many others. 
Honey 
Nutritional value per 100 g (3.5 oz) 
 
Energy  1,272 kJ (304 kcal) 
Carbohydrates  82.4 g 
- Sugars 82.12 g 
- Dietary fiber 0.2 g 
Fat 0 g 
Protein  0.3 g 
Water  17.10 g 
Riboflavin (vit. B2)  0.038 mg (3%) 
Niacin (vit. B3) 0.121 mg (1%) 
Pantothenic acid (B5) 0.068 mg (1%) 
Vitamin B6  0.024 mg (2%) 
Folate (vit. B9) 2 μg (1%) 
Vitamin C  0.5 mg (1%) 
Calcium 6 mg (1%) 
Iron 0.42 mg (3%) 
Magnesium  2 mg (1%) 
Phosphorus  4 mg (1%) 
Potassium 52 mg (1%) 
Sodium 4 mg (0%) 
Zinc  0.22 mg (2%) 
In medicine 
Historically, honey has been used by humans to treat a variety of ailments, 
from gastric disturbances to ulcers, wounds and burns, through ingestion or topical 
application, but only recently have the antiseptic and antibacterial properties of 
honey been chemically explained. Different honeys have different properties, 
which was known since ancient times. Much scientific research has been done, 
with emphasis of late on fighting infections in wounds. The antibacterial 
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mechanisms known to date are H2O2, methylglyoxal(MGO), bee defensin-1, the 
osmotic effect and the pH.  
In Ayurveda, a 4000-year-old treatise on medicine originating from India, 
honey is considered to positively affect all three primitive material imbalances of 
the body. "Vaatalam guru sheetam cha raktapittakaphapaham Sandhatru 
cchedanam ruksham kashayam madhuram madhu|| "It has sweetness with added 
astringent as end taste. It is heavy, dry and cold. Its effect on doshas (imbalances) 
is that it aggravates vata (air / moving forces), scrapes kapha (mucus / holding 
forces) and normalizes pitta (catabolic fire) and rakta (blood). It promotes the 
healing process." Some wound gels which contain antibacterial raw honey and 
have regulatory approval are now available to help treat drug-resistant strains of 
bacteria (MRSA). One New Zealand researcher says a particular type of honey 
(manuka honey) may be useful in treating MRSA infections. 
As an antimicrobial agent honey is useful in treating a variety of ailments. 
Antibacterial properties of honey are the result of the low water activity causing 
osmosis, chelation of free iron, its slow release of hydrogen peroxide, high acidity, 
and the antibacterial activity of methylglyoxal. 
Honey appears to be effective in killing drug-resistant biofilms which are 
implicated in chronic rhinosinusitis. 
Botulism 
Because of the natural presence of botulinum endospores in honey, children 
under one year of age should not be given honey. The more-developed digestive 
system of older children and adults generally destroys the spores. Infants, however, 
can contract botulism from honey. Medical grade honey can be treated with 
gamma radiation to reduce the risk of botulinum spores being present. Gamma 
radiation evidently does not affect honey's antibacterial activity, whether or not the 
particular honey's antibacterial activity is dependent upon peroxide generation. 
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Infantile botulism shows geographical variation. In the UK, only six cases 
have been reported between 1976 and 2006,yet the U.S. has much higher rates: 1.9 
per 100,000 live births, 47.2% of which are in California. While the risk honey 
poses to infant health is small, it is recommended not to take the risk. 
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rq;F 
 rq;F xU XLila gpuhzp. ,J xU tif fly; G+r;rpapd; clyhFk;. 
nky;ypa cliyg; ngw;w rq;F G+r;rpfs; KJF vYk;G mw;wit. rq;fpd; 
clypypUe;J Ruf;Fk; xU tpj Rug;gpiaf; nfhz;L jpUfshd fbdkhd 
$l;il cUthf;fpf; nfhs;fpwJ. ,ij ehk; rq;F vd;fpNwhk;. rq;F fly; 
ePhpypUe;J vspjpy; Rz;zrj;ij gphpj;J> mjd; %yk; cWjpahd Xl;il 
cUthf;FfpwJ.  
 rq;F Rz;zr; rj;J epuk;gpapUg;gjhy;> Foe;ijfSf;F rq;fpy; ghy; 
Cw;wpf; nfhLf;f> vd;GUf;fp Neha; Vw;glhky; jLf;fyhk; vd;W 
fUjg;gLfpwJ.  
 Rz;zhk;G rj;J kpFe;J fhzg;gLtjhy;> nfhLf;fg;gl Ntz;ba 
mstpw;F kpQ;rpd;> Rz;zhk;gpdhy; cz;lhFk; eQ;Rf; Fwp Fzq;fs; 
Njhd;Wk;.  
eQ;Rf; Fwp Fzk;:- 
 Rz;zhk;ig cl;nfhz;lTld; tha;> ehf;F> njhz;il Kjypad 
mow;rpailAk;> gpwF mf;fuk; Nghy; tha; rpte;Jk;> nky;ypaNjhy; nte;Jk; 
Gz;zhFk;. tapw;wpy; vhpr;ry; cz;lhFk;. the;jpAk; fopr;rYk; Vw;gLk;. 
KwpT 
 Rz;zhk;gpd; Ntfj;ijg; Nghf;f Njq;fha;g; ghy;> ntz;nza;> 
nea; Kjypaitfisf; nfhLf;f Ntz;Lk;.  
 FUjpiaf; Fzg;gLj;j ‘ntz;nza; gw;gk;” my;yJ ‘Fq;fpypa 
ntz;nza;” my;yJ ‘JtHg;Gs;s FbePH” Mfpaitfisf; 
nfhLf;fyhk;. kQ;ris ehf;fpy; jlt Ntz;Lk;. 
 kQ;ris miuj;Jj; jz;zPhpw; fyf;fp tbfl;ba ePiuf; 
nfhLf;fyhk;.  
 vUik Nkhiuf; nfhLf;fyhk;. 
  ,jdhy; Rz;zhk;G cz;l eQ;rpd; Ntfk; ePq;Fk;. 
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CONCH SHELL 
Biomineralization 
Biomineralization is the process by which living organisms produce 
minerals, often to harden or stiffen existing tissues. Such tissues are called 
mineralized tissues. It is an extremely widespread phenomenon; all six taxonomic 
kingdoms contain members that are able to form minerals, and over 60 different 
minerals have been identified in organisms. Examples include silicates in algae 
and diatoms, carbonates in invertebrates, and calcium phosphates and carbonates 
in vertebrates. These minerals often form structural features such as sea shells and 
the bone in mammals and birds. Organisms have been producing mineralised 
skeletons for the past 550 million years. Other examples include copper, iron and 
gold deposits involving bacteria. Biologically-formed minerals often have special 
uses such as magnetic sensors in magnetotactic bacteria (Fe3O4), gravity sensing 
devices (CaCO3, CaSO4, BaSO4) and iron storage and mobilization (Fe2O3•H2O in 
the protein ferritin). 
In terms of taxonomic distribution, the most common biominerals are the 
phosphate and carbonate salts of calcium that are used in conjunction with organic 
polymers such as collagen and chitin to give structural support to bones and shells. 
The structures of these biocomposite materials are highly controlled from the 
nanometer to the macroscopic level, resulting in complex architectures that 
provide multifunctional properties. Because this range of control over mineral 
growth is desirable for materials engineering applications, there is significant 
interest in understanding and elucidating the mechanisms of biologically 
controlled biomineralization. 
A mollusc shell is formed, repaired and maintained by a part of the anatomy 
called the mantle. Any injuries to or abnormal conditions of the mantle are usually 
reflected in the shape and form and even color of the shell. When the animal 
encounters harsh conditions that limit its food supply, or otherwise cause it to 
become dormant for a while, the mantle often ceases to produce the shell 
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substance. When conditions improve again and the mantle resumes its task, a 
"growth line" is produced. 
The shell-secreting area is differentiated very early in embryonic 
development. An area of the ectoderm thickens, then invaginates to become a 
"shell gland". The shape of this gland is tied to the form of the adult shell; in 
gastropods, it is a simple pit, whereas in bivalves, it forms a groove which will 
eventually become the hinge line between the two shells, where they are connected 
by a ligament. The gland subsequently evaginates in molluscs that produce an 
external shell. Whilst invaginated, a periostracum - which will form a scaffold for 
the developing shell - is formed around the opening of the invagination, allowing 
the deposition of the shell when the gland is everted. A wide range of enzymes are 
expressed during the formation of the shell, including carbonic anhydrase, alkaline 
phosphatase, and DOPA-oxidase (tyrosinase)/peroxidase.
 
Chemistry 
The formation of a shell in molluscs appears to be related to the secretion of 
ammonia, which originates from urea. The presence of an ammonium ion raises 
the pH of the extrapallial fluid, favouring the deposition of calcium carbonate. 
This mechanism has been proposed not only for molluscs, but also for other 
unrelated mineralizing lineages. 
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Calcium Overdose 
 
Calcium is an important minearal. While a deficiency in calcium is certainly 
common, it is also possible to take too much calcium. For nutrients that can cause 
toxicity, a “Tolerable Upper Intake Level” is given. This is the maximum that can 
be taken (from all sources, including the diet) without causing significant toxicity. 
The UL of calcium for infants upto 12 months old has not been established. The 
Tolerable Upper Intake Level (UL) of calcium for everyone else is 2500 mg 
(2.5gms) daily. A calcium overdose can cause significant side effects. 
High calcium levels in the blood lead to a condition known as 
hypercalcemia.  
 
Causes for hypercalcemia  
 From natural food sources. 
(or) 
 From calcium supplements. 
(or) 
 Vitamin D supplement that increase calcium absorption in the body.  
 
Symptoms 
 Abdominal Pain 
 Bone Pain 
 Coma 
 Confusion 
 Constipation (or) Diarrhoea  
Depression  
 Headache  
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 Irregular heartbeat 
 Muscle twitching, 
 Nausea 
 Vomitting. 
 
 
ONE – TIME OVERDOSE / ACUTE OVERDOSE 
 The symptoms of single, acute overdose from accidentally or intentionally 
taking  too many calcium supplements or calcium containing antacids at one time 
include stomachache, constipation or diarrhoea, headache, nausea and vomiting. 
An overdose can ultimately lead to mental confusion, irregular heart beat, high 
blood pressure and coma.  
 
ANTACID OVERDOSE 
 Rarely a condition called milk – alkali syndrome (or) calcium – alkali 
syndrome can occur with hypercalcemia when large amounts of calcium and alkali 
in antacids are consumed to control heart burn or used simply as a calcium 
supplement. Left untreated, milk – alkali syndrome can lead to tissue calcification 
and kidney failure.  
 
CHRONIC SUPPLEMENT OVERUSE 
 Chronic high blood levels of calcium can result in kidney stone formation, 
kidney damage and failure abnormal heart rhythms, calcification in the areas of the 
body other than bone tissue, dementia and come. Too much calcium can also 
interfere with iron absorption. 
 Symptoms of mild hypercalcemia are almost nonexistent, while symptoms 
of more hypercalcemia are similar to those of an acute overdose. In addition, 
frequent urination and excessive thirst may signal hypercalcemia. A routine blood 
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test indicating high levels of calcium in the blood is the first indication of 
hypercalcemia. 
 
TREATMENT 
    Usually focused on diluting the concentration of calcium in the body and 
then encouraging its excretion. This is done primarily through hydrating the patient 
and then introducing a diuretic. Drugs such as calcitonin can be used to block the 
uptake of calcium and encourage excretion. 
Activated charcoal can be used as an antidote. 
Gastric lavage may be done if necessary.  
 
PROGNOSIS : 
Chronic overuse is more serious than a single overdose. Few patients die 
from an antacid overdose. 
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MATERIALS AND METHODS 
Selection of Drugs:  
 “SANGU PARPAM” as mentioned in the text Anupoga vaithiya 
navancetham – part III page no. : 11 was chosen.  
 The raw drug was bought from raw drug stores, thakkalai and the medicine 
prepared with great caution as per the procedure mentioned below.  
Ingredients:  
  Purified Sangu - 1 palam (35 gms) 
  Aloe juice  - Required amount. 
Method of Purification:  
 Sangu (Conch shell) – 1 palam (35 gms)  
Equal weight of Lime stone and Uvarman was mixed with water. The water 
in the upperpart was taken and Sangu was immersed in it. Then it was boiled until 
the water was fully evaporated. Then the sangu was washed in pure water and the 
weight was taken. 
- Gunapadam thathu jeeva vaguppu Pg. 642. 
Method of Preparation:  
 Sangu is powdered in the Kalvam. Then aloe juice is added little by little 
and it is ground for 6 hours. Then it is made into villai and dried. Then villai are 
placed in an agal and covered with another agal and it is sealed with clay cloth and 
dried. It is then subjected to pudam with 100 palam varatti. On being cooled, it is 
taken out, powdered, weighed and bottled up. 
 Dose of the drug  :  1 – 2 Kunri (130 – 260 mg) 
  Adjuvant   : Honey  
 Therapeutic use  : Elumburuki 
Ref. Anupoga vaithiya navaneethan part – III page no. – 11. 
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SAMPLES SENT FOR ANALYSIS  
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PHYSICOCHEMICAL ANALYSIS  
Sample Description  :  SANGU PARPAM 
Equipment used  : Atomic Absorption Spectrometer (AAS)  
Colour:  
 About 50g of SANGU PARPAM was taken in a clean glass beaker and 
tested for its colour by viewing again a white opaque background under direct 
sunlight.  
pH:  
 The pH of SANGU PARPAM was estimated as per the method prescribed 
in Indian Standard (IS) – 6940 (1982). One gram of the SANGU PARPAM was 
taken into a 100ml graduated cylinder containing about 50ml of water and filled 
upto the mark with water. The cylinder was stopped and shaken vigorously for two 
minutes and the suspension was allowed to settle for an hour at 25
0
 to 27
0
. About 
25ml of the clear aqueous solution was transferred into a 50ml beaker and tested 
for ph using DIGISUN digital pH meter (DIGISUN Electronics, Hyderabad, 
India). 
Determination of Ash Value:  
 Weighed accurately 2 grams of SANGU PARPAM in tarred platinum or 
silica dish and incinerate at a temperature not be exceeding 45
0
 c until free from 
carbon, cooled, and weighed. Calculate the percentage of ash with reference to the 
air dried drug.  
Water Soluble Ash:  
 To the gooch crucible containing to the total ash, added 25ml of water and 
boiled for 5 minutes. Collected the insoluble matter in a sintered glass crucible or 
on ash less filter paper, wash with hot water and ignite in a crucible for 15 minutes 
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at a temperature not exceeding 450
0
C. Substract the weight of the insoluble matter 
from the weight of the ash the difference of the weight represents the water soluble 
ash. Calculate the percentage of water soluble ash with reference to the air dried 
drug.  
Acid Insoluble Ash:  
 Boiled the ash 5 minutes with 25ml of 1:1 dil HCL. Collect the insoluble 
matter in gooch crucible on an ash less filter paper wash with hot water and ignite. 
Cooled in a desiccators and weighed calculated the percentage of acid insoluble 
ash with reference to the air dried drug.  
Loss on Drying:  
 Five grams of SANGU PARPAM is heated in a hot oven at 105
0
c to 
constant weight and the percentage of loss of weight was calculated there from.  
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INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROMETRY (ICP – OES)  
Introduction 
 The elemental composition of a sample is often an important part of the 
information need to assess its properties. Hence there is a need for sensitive 
scientific instrumentation like ICP – OES which plays a pivotal role in the 
determination of these elements. ICP – OES is widely employed for the estimation 
of metals and metalloids at trace, minor and major concentrations.  
Principle 
 In this technique, the high temperature plasma source atomizes the sample 
and excites the atoms resulting in emission of photons. The atoms of each element 
in the sample emit specific wavelength of light. The emission spectrum from the 
plasma is dispersed by an optical spectrometer, so that intensities of the individual 
wavelength can be measured. The number of photons emitted is directly 
proportional to the concentration of the element. The photon may be detected 
either sequentially or simultaneously. Quantitative analysis is achieved by 
measuring the intensity of these specific wavelengths and after performing the 
calibration using known standards.  
Extraction of information 
 Obtaining qualitative information, i.e., what elements are present in the 
sample, involves identifying the presence of emission at the wavelengths 
characteristic of the elements of interest. Obtaining quantitative information, i.e., 
how much of an element is in the sample, can be accomplished using plots of 
emission intensity versus concentration called calibration curves. Typical 
calibration graph is illustrated bellow. 
 
 
59 
 
Experimental Procedure: Done at SAIF, IIT Madras, Chennai – 36  
Sample preparation – Microwave Digestion  
 Weigh 0.25gm of test sample and transfer into a liner provided with the 
instrument.  
 Slowly add 9 ml of Nitric acid or Sulphuric acid such that no piece of 
sample sticks on the slides.  
 Mix thoroughly and allow reacting for few minutes.  
 Place the liner in the vessel jacket.  
 Close the screw cap hand – tight in clock wise direction.  
 Seal the vessel and place in the rotor fixed in microwave.  
 Set temperature to 1800C for 5 minutes; hold at 1800C for least 10 minutes.  
 Allow the vessels to cool down to a vessel interior temperature below 600C 
and to a vessel surface temperature (IR) below 50
0
C before removing the 
rotor.  
 The digested sample was made upto 100ml with Millipore water. 
 If visible insoluble particles exist, solution could be filtered through 
Whatmann filter paper.  
 Transfer the digested solution into plastic containers and label them 
properly.  
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SCANNED ELECTRON MICROSCOPY (SEM) 
 A SEM is essentially a high magnification microscope, which uses a 
focused scanned electron beam to produce images of the sample, both top – down 
and, with the necessary sample preparation, cross – sections. The primary electron 
beam interacts with the sample in a number of key ways: -  
 Primary electrons generate low energy secondary electrons, which tend to 
emphasize the topographic nature of the specimen.  
 Primary electrons can be backscattered which produces images with a high 
degree of atomic number (Z) contrast.  
 Ionized atoms can relax by electron shell – to – shell transitions, which lead 
to either X – ray emission or Auger electron ejection. The X –rays emitted 
are characteristic of the elements in the top few µm of the sample.  
The SEM is carried out by using FEI – Quanta FEG 200 – High Resolution 
Instrument.  
Resolution    :  1.2nm gold particle separation on a carbon substrate  
Magnification : From a min of 12 x to greater than 1,00,000 X  
Application   : To evaluate grain size, particle size distributions, material  
homogeneity and inter metallic distributions 
Sample preparation:  
 Sample preparation can be minimal or elaborate for SEM analysis, 
depending on the nature of the samples and the data required. Minimal preparation 
includes acquisition of a sample that will fit into the SEM chamber and some 
accommodation to prevent charge build – up on electrically insulating samples. 
Most electrically insulating samples are coated with a thin layer of conducting 
material, commonly carbon, gold, or some other metal or alloy. The choice of 
material for conductive coatings depends on the data to be acquired: carbon is 
most desirable if elemental analysis is a priority, while metal coatings are most 
effective for high resolution electron imaging applications. Alternatively, an 
electrically insulating sample can be examined without a conductive coating in an 
instrument capable of “low vacuum” operation. 
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FOURIER TRANSFORM – INFRA RED SPECTROSCOPY  
PERKIN ELMER – SPECTRUM ONE 
Introduction 
 Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular structure. The spectral bands can be assigned to different vibrational 
modes of the molecule. The various functional groups present in the molecule can 
be assigned by a comparison of the spectra with characteristic functional group 
frequencies. As the positions of the bands are directly related to the strength of the 
chemical bond, a large number of investigations including intermolecular 
interactions, phase transitions and chemical kinetics can be carried out using this 
branch of spectroscopy.  
 In IR spectroscopy, the resonance absorption in made possible by the 
change in dipole moment accompanying the vibrational transition. The Infrared 
spectrum originates from the vibrational motion of the molecule. The vibrational 
frequencies are a kind of fingerprint of the compounds. This property is used for 
characterization of organic, inorganic and biological compounds. The band 
intensities are proportional to the concentration of the compound and hence 
qualitative estimations are possible. The IR spectroscopy is carried out by using 
Fourier transform technique. 
Principle 
 Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction, electromagnetic radiation 
characteristic of the interacting system may be absorbed (or emitted). The 
experimental data consist of the nature (frequency of wave length) and the amount 
(intensity) of the characteristic radiation absorbed or emitted. These data are 
correlated with the molecurlar and electronic structure of the substance and with 
intra – and inter molecular interactions.  
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 FT–IR spectroscopy is used primarily for qualitative and quantitative 
analysis of organic compounds, and also for determining the chemical structure of 
inorganic materials. The region between 500 – 4000 wave numbers is referred to 
as the finger print region. Absorption bands in this region are generally due to 
intra molecular phenomena and are highly specific for each material. The 
specificity if these bands allow computerized data searches to be performed 
against reference libraries to identify a material.  
Table of Characteristic IR Absorptions 
Frequency, cm – 1 Bond Functional group 
3640 – 3610 (s, sh) O – H stretch 
free hydroxyl alcohols, 
phenols 
3500 – 3200 (s,b) O – H stretch, H – bonded alcohols, phenols 
3400 – 3250 (m) N – H stretch 
primary, secondary 
amines, amides 
3300 – 2500 (m) O – H stretch carboxylic acids 
3330 – 3270 (n, s) 
- C (triple bond) C – H : 
C – H stretch 
alkynes (terminal) 
3100 – 3000 (s) C – H stretch aromatics  
3100 – 3000 (m) = C – H stretch alkenes 
3000 – 2850 (m) C – H stretch  alkenes 
2830 – 2695 (m) H – C = 0; C – H stretch aldehydes 
2260 – 2210 (v) C (triple bond) N stretch nitriles 
2260 – 2100 (w) C (triple bond) C - stretch alkynes 
1760 – 1665 (s) C = 0 stretch carbonyls (general) 
1760 – 1690 (s) C = 0 stretch carboxylic acids 
1750 – 1735 (s) C = 0 stretch esters, saturated aliphatic 
1740 – 1720 (s) C = 0 stretch aldehydes, saturated 
aliphatic 
1730 – 1715 (a) C = 0 stretch 
alpha, beta – unsaturated 
esters 
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1715 (s) C = 0 stretch 
ketones, saturated 
aliphatic 
1710 – 1665 (s) C = 0 stretch 
alpha, beta – unsaturated 
aldehydes, ketones 
1680 – 1640 (m) -C = C – alkenes 
1650 – 1580 (m) N – H bend primary amines 
1600 – 1585 (m) C – C stretch (in – ring) aromatics 
1550 – 1475 (s) N – 0 asymmetric stretch  nitro compounds  
1500 – 1400 (m) C – C stretch (in – ring) aromatics 
1470 – 1450 (m) C – H bend alkanes 
1370 – 1350 (m) C – H rock alkanes 
1360 – 1290 (m) N – 0 symmetric stretch nitro compounds  
1335 – 1250 (s) C – N stretch aromatic amines 
1320 – 1000 (s) C – 0 stretch 
alcohols, carboxylic 
acids, esters, ethers 
1300 – 1150 (m) C – H wag ( - CH2X) alkyl halides 
1250 – 1020 (m) C – N stretch aliphatic amines 
1000 – 650 (s) =C – H bend alkynes 
950 – 910 (m) O – H bend carboxylic acids 
910 – 665 (s, b) N – H wag 
primary, secondary 
amines 
900 – 675 (s) C – H “oop” aromatics 
850 – 550 (m) C – CI stretch alkyl halides 
725 – 720 (m) C – H rock alkynes 
700 – 610 (b,s) 
- C (triple bond) C–H : C 
– H bend 
alkynes 
690 – 515 (m) C – Br stretch alkyl halides 
 
m = medium, w = weak, s = strong, n = narrow, b = broad, sh = sharp 
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Sampling techniques:  
 There are a variety of techniques for sample preparation depending on the 
physical form of the sample to be analyzed.  
 Solid  : KBr or Nujol mull method.  
 Liquid : CsI / TlBr Cells 
 Gas : Gas cells 
Experimental Procedure: Done at SAIF, IIT Madras, Chennai – 36.  
KBr Method 
 The sample was grounded using – an agate mortar and pestle to give a very 
fine powder.  
 The finely powder sample was mixed with about 100 mg dried KBr salt.  
The mixture was then pressed under hydraulic press using a die to yield a 
transparent disc (measure about 13 mm diameter and 0.3mm in thickness), 
through which the beam of spectrometer passed. 
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Preclinical toxicity studies  
Siddha system an ancient system of medicine was introduced by the 
SIDDHAR‟s. On the basis of application of the medicines are divided into internal 
uses as well as external uses. In order to standardize such medicines, it is necessary 
to evaluate its safety and also to find whether it possess toxic properties or not. So 
toxicity studies are conducted on animals.  
General principles of Toxicity studies:  
 Usually toxicity studies are conducted on test animals like mice, albinorats, 
rabbits and dogs. By this research methodology acute, subacute and chronic 
toxicities have to be carried out.  
 While doing animal study, there are some criteria and condition to be noted. 
They are given below.  
Selection of Animal species:  
1. Generally young and immature animals should be selected for the study.  
2. In case of mice, it should be 20 – 25 gm weight and 8 – 12 weeks of 
growth.  
3. In case of albinorats, it should be 80 – 120 gm and 12 weeks growth.  
4. Virgin animals should be selected.  
Preparation of animals: 
1. Animals are kept properly in cages and should be fed properly with 
adequate diet.  
2. Animals brought from outside are allowed to get acclimatized in the cages 
for about 5 days.  
3. Animal house should be maintained at a temperature of 190C and 250C and 
its humidity should be 30%. 
4.   The animals are kept 12 hours in dark and 12 hours in light.  
5. The test animal must be free from infections.  
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Preparation of test drug:  
1. The drug should be soluble in honey, water or any other liquid, so that it 
can be administered orally.  
2. The drug should be stable. 
3. The drug should be prepared whenever necessary.  
4. Drug should not have hyperacidity or hyperalkalinity and high toxicity.  
Preparation of the doses:  
1. Depending on the weight of the animal the dose should be determined.  
2. When water soluble drugs are given, it must be 2ml/ 100gm body weight.  
3. The adjuvant (anubanam) should be free from toxicity.  
Procedure:  
a) Administration of Drug:  
 During drug administration care should be taken that the drug does not enter 
into the Respiratory passage. Before drug administration, the animal has to be 
fasted. In case of mice and albino rat the fasting period is 3 hours and 12 hours 
respectively. The weight of the animal has to be noted before drug administration. 
Then the drug is administered to the animal. After administration of the drug, the 
animal should be fed after a lapse of 1 – 2 hours in mice and 3 – 4 hours in albino 
rats.  
b) Number of animals and dose levels:  
 The dose of the drug given in the animal depends upon  
1. Body weight of the animal. 
2. Metabolic rate of the animal. 
While conduction acute toxicity study the number of animals in each group 
should be five (i.e. 6 groups). Animals of both sexes should be used. In case 
of chronic toxicity study the animals are divided into 3 groups, each group 
consisting of 5 animals.  
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Observation:  
 In acute toxicity study, the animals are carefully observed during the first 
30 minutes and then observed for 24 hours. During that period, the animal may 
show changes in the skin, eye, mucous membrane, blood  circulation, respiratory 
movements and the neurological problems may arise.  
 For chronic toxicity study the animals have to be observed for 90 days or 
sometimes upto 1 year. Some researchers conduct the chronic toxicity study for the 
whole life time of the animal. 
Body weight of the animal:  
 The weight of the animal must be taken during the course of study.  
1. First before drug administration 
2. One week after drug administration 
3. Two weeks after drug administration 
4. Regularly recorded in a fixed interval during the period of drug 
administration. 
5. Finally before sacrificing the animal. 
Toxicity study:  
 The toxicity evaluation of SANGU PARPAM is carried out in 2 phases.  
  Phase I  – Acute toxicity study  
  Phase II – Chronic toxicity study  
Data and Report:  
 At the end of the animal study, the following data‟s must be given.  
1. Number of animals selected for the study.  
2. Number of animals died due to the toxicity of the drug given.  
3. Number of animals sacrificed at the end of animal study.  
4. Changes in animal behavior due to acute and chronic toxicity.  
5. Histopathological changes in the internal organs such as liver, kidney, heart. 
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ACUTE TOXICITY STUDIES 
Animal:  
 Wistar albino rat bred in the animal house attached to the Post Graduate, 
Pharmacology Department, Government Siddha Medical College, Palayamkottai 
were used.  
Sex:  
 Animals of both sexes were used.  
Weight:  
 Animals weighing between 80 – 120 gms were selected  
Feeding of the animals:  
 The animals were randomly selected and kept in their cages. Conventional 
laboratory diet was used with unlimited supply of drinking water.  
Separation of animals into groups:  
 30 rats were divided into 6 groups, each group consists of 5 rats. One group 
is kept as control, by giving water alone.  
Dose levels of the drug: 
 The following ascending dose levels were fixed by presuming a range of 
atleast toxic to high toxic doses.  
 I Group - Control 
 II Group - 100 mg / body weight of animal 
 III Group  - 200 mg / body weight of animal 
 IV Group - 400 mg / body weight of animal 
 V Group - 800 mg / body weight of animal 
 VI Group - 1600 mg / body weight of animal 
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Route of administration:  
 Oral administration.  
Drug preparation for administration: 
 The drug was weighed and taken and Honey was added as a suspending 
agent. It was ground well before administration. The preparation was done in such 
a way that 2 ml of suspension contained 100mg – 1600mg of the drug. The drug 
was administered once in a day during the experiment.  
Observation:  
 The following details were recorded.  
I. Stimulation:  
 Hyperactivity 
 Pyloerection 
 Twitching 
 Rigidity 
 Irritability 
 Jumping  
 Clonic convulsion 
 Tonic convulsion 
II. Depression :  
 Ptosis 
 Sedation 
 Sleep 
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 Loss of Pinna reflex 
 Ataxia 
 Loss of muscle tone 
 Analgesia  
III. Autonomic effect:  
 Straub tail 
 Laboured Respiration 
 Cyanosis 
 Blanching  
 Reddening  
 Abnormal secretion 
IV. No of animals dead:  
 At the end of 24 hours, the number of animals live or dead in each group 
was noted and approximate ED50 is tried to determine. The tabular column was 
made and the results were analysed.  
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CHRONIC TOXICITY STUDY 
 „SANGU PARPAM‟ is used for the treatment of Elumburuki.  
 Since the drug is usually used on a long term basis for chronic ailments, it 
was decided to find the chronic toxic potentiality of the SANGU PARPAM in 
experimental animals called Wistar albino rats.  
SELECTION OF ANIMALS 
 Wistar albino rats bred in the animal house attached to the post graduate, 
Pharmacology Department, Government Siddha Medical College, Palayamkottai 
were used.  
SEX 
 Animals of both sexes were used. 
WEIGHT 
 Animals weighing between 80 – 120 gms.  
FOOD AND WATER 
 The animals were maintained with standard animal feed and water. 
NUMBER OF ANIMALS 
 15 albino rats were divided into 3 groups, each group consisting of 5 rats.  
DOSE LEVELS 
Selection of dose level  
 Two doses were selected from the acute toxicity study. These doses did not 
have any acute toxicity effect and presumed to be safe for long term administration 
in animals.  
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 I Group  Control 
 II Group  100 mg / 100 gm body weight of animal 
 III Group  200 mg / 100 gm body weight of animal 
ROUTE OF ADMINISTRATION 
 The drug was administered orally for about 90 days.  
PREPARATION OF DOSE FOR ALBINO RATS  
 The drug was weighted and taken and suspended in Honey. The mixture 
was ground well before the administration. The preparation was done in such a 
way that 1 ml of suspension contains dose ranging from 100 mg / ml and 200 mg / 
ml of SANGU PARPAM for the groups taken. The prepared drug was 
administrated once a day (morning) for 90 days. 
OBSERVATION 
 The following details were recorded before the beginning of the drug 
administration.  
1. Body weight of the animal 
2. Hematological investigation  
a. W.B.C. Total count  
b. W.B.C. Differential count  
c. Haemoglobin (%) 
Every month the above parameters were recorded and the results were tabulated. 
HISTOPATHOLOGICAL PROCEDURE 
 Histopathological study was conducted after 90 days. One animal from each 
group, were sacrificed at the end of the experiment and were dissected. The viscera 
was opened, Liver, Kidney and heart were removed from each animal and was 
preserved in 40% formalin solution for Histo – pathological studies.  
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The sections were stained with haemotoxillin & eosin and the 
histopathological report was given by Prof. Dr. Swaminathan, Head of 
Department, Department of Pathology, Tirunelveli Medical College and visiting 
Professor for Pathology to PG students of Govt. Siddha Medical College, 
Palayamkottai. 
The tabular column shown in tested parameters and changes in 
histopathological specimens were also documented.  
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BIO – CHEMICAL ANALYSIS OF SANGU PARPAM 
Preparation of the Extract:  
 100mg of the drug is weight accurately and placed into a clean beaker and 
added a few drops of cone. Hydrochloric acid and evaporated it well. After 
evaporation cooled the content and added a few drops of cone. Nitrie acid and 
evaporated it well. After coding the content add 20ml of distilled water and 
dissolved it well. Then it is transferred to 100ml volumetric flask and made up to 
100ml with distilled water. Mix well. Filter it. Then it is taken for analysis.  
QUALITATIVE ANALYSIS 
S.NO. EXPERIMENT OBSERVATION INFERENCE 
1.  TEST FOR CALCIM  
 2ml of the above prepared 
extract is taken in a clean test 
tube. To this add 2ml of 4% 
ammonium oxalate Solution. 
A white precipitate 
is formed. 
Indicates the 
presence of 
calcium. 
2.  TEST FOR SULPHATE 
 2ml of the extract is added 
to 5% Barium chloride solution. 
No white 
precipitate is 
formed. 
Indicates the 
absence of sulphate. 
3.  TEST FOR CHLORIDE 
 The extract is treated with 
Silver nitrate Solution. 
No white 
precipitate is 
formed. 
Absence of 
chloride. 
4.  TEST FOR CARBONATE 
 The extract is treated with 
Concentrated HCL. 
No brisk 
effervescence is 
formed. 
Absence of 
carbonate. 
5.  TEST FOR STARCH 
 The extract is added with 
weak iodine solution. 
No blue colour is 
formed. 
Absence of starch. 
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6.  TEST FOR FERRIC IRON 
 The extract is acidified 
with Glacial acetic acid and add 
Potassium ferro cyanide 
No blue colour is 
formed. 
Absence of Ferric 
Iron. 
7.  TEST FOR FERROUS IRON 
 The extract is treated with 
Concentrated nitric acid and 
Ammonium this cyanate 
solution. 
No blood red 
colour is formed. 
Absence of Ferrous 
Iron. 
8.  TEST FOR PHOSPHATE 
 The extract is treated with 
ammonium Molybdate and 
concentrated nitric acid. 
No yellow 
precipitate is 
formed. 
Absence of 
Phosphate. 
9.  TEST FOR ALBUMIN 
 The extract is treated with 
Esbatch‟s Reagent 
No yellow 
precipitate is 
formed. 
Absence of 
Albumin. 
10.  TEST FOR TANNIC ACID 
 The extract is treated with 
ferric Chloride. 
No blue black 
precipitate is 
formed. 
Absence of Tannic 
Acid. 
11.  TEST FOR UNSATURATION 
 potassium permanganate 
solution is added to the extract 
It does not get 
decolourised. 
Absence of zen 
saturated 
compound. 
12.  TEST FOR THE REDUCING 
SUGAR 
 5ml of Benedict‟s 
qualitative solution is taken in a 
test tube and allowed to boil for 2 
mins and add 8 – 10 drops of the 
extract and again boil it for 2 
mins.  
No colour change 
occurs. 
Absence of 
Reducing Sugar. 
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13.  TEST FOR AMINO ACID 
 Once or two drops of the 
extract is placed on a filter paper 
and dried it well. After drying 1 
% Ninhydrin is sprayed over the 
same and dried it well. 
No Violet colour is 
formed. 
Absence of Amino 
acid. 
14.  TEST FOR ZINC 
 The extract is treated with 
Potassium ferrocyanide. 
No white 
precipitate is 
formed. 
Absence of Zinc. 
 
Inference: 
 The given sample SANGU PARPAM contains calcium.  
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Table-1. 
Colour  characters of Sangu Parpam. 
 
S No 
 
Solvent used 
 
Under ordinary light 
 
Under ultra violet light 
 
1 PPM White  White 
PPM-Powdered plant material 
 
Table-2. 
Physicochemical properties of Sangu Parpam. 
 
S No. 
 
Parameters  
Values 
obtained 
(%w/w) 
Heavy/ toxic metals 
1 Total ash value  9.55 Lead BDL 
2 Acid insoluble ash  0.7 Cadmium BDL 
3 Water soluble ash  6.8 Mercury BDL 
4 Moisture content  10.48 Arsenic BDL 
5 Foreign organic matter  3.2   
 
 
Table-3. 
Colour, nature and percent yields of extracts of Sangu Parpam. 
 
S.no. 
 
Extract 
Solvent 
 
Colour 
 
Nature 
 
 
% 
Yield(w/w) 
 
SEM-Micro 
graph 
partical size 
range in nm 
 
pH 
1 Water White Solid 46  35 – 86 nm 8.9 - 9.9 
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SOPHISTICATED ANALYTICAL INSTRUMENT FACILITY 
IITM,CHENNAI-36 
PERKIN ELMER OPTIMA 5300DV ICP-OES 
 
 
SampleID Analyte Mean 
 
Shell B.P------------------------------------------------------------------------------------------------ 
  
 
     As193.696  BDL 
 
 Ca 317.933 500.210 mg/L 
                                   .  
       Cd 226.502               BDL 
 
 Hg253.652                BDL 
 
   K 766.490  5.170 mg/L 
 
  Na 589.592  11.598  mg/L 
 .  
 Pb 230.204                BDL 
 
BDL=Below  detection limit 
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SOPHISTICATED ANALYTICAL INSTRUMENT FACILITY 
IITM,CHENNAI-36 
PERKIN ELMER OPTIMA 5300DV ICP-OES 
 
 
SampleID Analyte Mean 
 
 
Shell A.P ----------------------------------------------------------------------------------------------- 
   
     As193.696  BDL 
 
 Ca 317.933 250.325 mg/L 
                                   .  
       Cd 226.502               BDL 
 
 Hg253.652                BDL 
 
   K 766.490  2.574 mg/L 
 
  Na 589.592  6.741  mg/L 
 .  
 Pb 230.204               BDL 
 
 
BDL=Below  detection limit 
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SOPHISTICATED ANALYTICAL INSTRUMENT FACILITY 
IITM,CHENNAI-36 
PERKIN ELMER OPTIMA 5300DV ICP-OES 
 
SampleID Analyte Mean 
 
Shell A.O.P--------------------------------------------------------------------------------------------- 
   
       As193.696  BDL 
 
 Ca 317.933 124.865 mg/L 
                                   .  
       Cd 226.502                BDL 
 
 Hg253.652                BDL 
 
   K 766.490  1.245 mg/L 
 
  Na 589.592  3.149 mg/L 
  .  
 Pb 230.204                BDL 
 
  
 
 .  
BDL=Below  detection limit 
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SOPHISTICATED ANALYTICAL INSTRUMENT FACILITY 
IITM,CHENNAI-36 
PERKIN ELMER OPTIMA 5300DV ICP-OES 
 
SampleID Analyte Mean 
 
   
Sangu  Parpam---------------------------------------------------------------------------------------- 
   
 
     As193.696  BDL 
 
 Ca 317.933 100.295 mg/L 
                                   .  
       Cd 226.502                BDL 
 
 Hg253.652                 BDL 
 
   K 766.490  0.542 mg/L 
 
  Na 589.592  2.641 mg/L 
  .  
 Pb 230.204                BDL 
 
BDL=Below  detection limit 
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FTIR - METHOD 
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Frequency, cm – 1 Functional Group 
3640 – 3610 (s, sh) - 
3500 – 3200 (s,b) + 
3400 – 3250 (m) - 
3300 – 2500 (m) - 
3330 – 3270 (n, s) - 
3100 – 3000 (s) - 
3100 – 3000 (m) - 
3000 – 2850 (m) - 
2830 – 2695 (m) - 
2260 – 2210 (v) - 
2260 – 2100 (w) - 
1760 – 1665 (s) + 
1760 – 1690 (s) - 
1750 – 1735 (s) - 
1740 – 1720 (s) - 
1730 – 1715 (a) - 
1715 (s) - 
1710 – 1665 (s) - 
1680 – 1640 (m) - 
1650 – 1580 (m) - 
1600 – 1585 (m) - 
1550 – 1475 (s) - 
1500 – 1400 (m) - 
1470 – 1450 (m) - 
1370 – 1350 (m) - 
1360 – 1290 (m) - 
1335 – 1250 (s) - 
1320 – 1000 (s) - 
1300 – 1150 (m) - 
84 
 
1250 – 1020 (m) + 
1000 – 650 (s) - 
950 – 910 (m) - 
910 – 665 (s, b) - 
900 – 675 (s) - 
850 – 550 (m) - 
725 – 720 (m) - 
700 – 610 (b,s) - 
690 – 515 (m) + 
 
m – Medium 
w – Wead 
s – Strong 
n – Narrow 
b – Broad 
sh – Shock 
 
Result: 
 The given sample of Sangu parpam contains alcohols, Phenols, Carbonyls, 
aliphatic amines and alkyl halides. 
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SEM RESULT  
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Inference: - 
 From the above reports it is observed that the sample couch shell (Sangu) 
after purification contains heavy metals like arsenic, cadmium, mercury, lead 
found to be below detection limit and the concentration of calcium, potassium and 
sodium are found to be decreased when compared with the sample of conch shell 
(sangu) before purification.  
 The concentration of metals present in the samples are decreased during 
processing. Thus the finished medicine Sangu Parpam contains heavy metal 
concentration under the detection limit and required concentration of nutritional 
and essential minerals.  
Result: - 
1. pH range   : 8.9 – 9.9 
2. FTIR data : Given sample contains alcohols, Phenols,  
Carbonyls, aliphatic amines and alkyl halides 
3. HR SEM  : Particle size in the range of 400 nm. 
4. ICP data  :  shows Ca, k, Na 
(100.295, 0.542, 2.641 / ppm).  
Impression:  
 Sangu Parpam shows major percentage of oxides of calcium and sodium 
and traces of potassium. 
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TABLE NO. I 
SHOWS THE RESULTS OF ACUTE TOXICITY STUDY OF “SANGU 
PARPAM” AT A CONTROL DOSE 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I.  Stimulation :     
Hyper activity  - - - - 
Pyloerection  - - - - 
Twitching - - - - 
Rigidity  - - - - 
Irritability - - - - 
Jumping - - - - 
Clonic convulsion - - - - 
Tonic convulsion - - - - 
II. Depression:     
Ptosis - - - - 
Sedation - - - - 
Sleep - - - - 
Loss of pinna reflex - - - - 
Ataxia - - - - 
Loss of muscle tone - - - - 
Analgesic - - - - 
III. Autonomic effects:     
Straub tail - - - - 
Laboured respiration - - - - 
Cyanosis - - - - 
Blanching - - - - 
Reddening - - - - 
IV. Number of animals dead    
+ Positive sign – Negative sign   
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TABLE NO. II 
SHOWS THE RESULTS OF ACUTE TOXICITY STUDY OF “SANGU 
PARPAM” AT A DOSE OF 100 mg / 100 gm BODY WEIGHT OF ANIMAL 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I.  Stimulation :     
Hyper activity  - - - - 
Pyloerection  - - - - 
Twitching - - - - 
Rigidity  - - - - 
Irritability - - - - 
Jumping - - - - 
Clonic convulsion - - - - 
Tonic convulsion - - - - 
II. Depression:     
Ptosis - - - - 
Sedation - - - - 
Sleep - - - - 
Loss of pinna reflex - - - - 
Ataxia - - - - 
Loss of muscle tone - - - - 
Analgesic - - - - 
III. Autonomic effects:     
Straub tail - - - - 
Laboured respiration - - - - 
Cyanosis - - - - 
Blanching - - - - 
Reddening - - - - 
IV. Number of animals dead    
+ Positive sign – Negative sign   
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TABLE NO. III 
SHOWS THE RESULTS OF ACUTE TOXICITY STUDY OF “SANGU 
PARPAM” AT A DOSE OF 200 mg / 100 gm BODY WEIGHT OF ANIMAL 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I.  Stimulation :     
Hyper activity  - - - - 
Pyloerection  - - - - 
Twitching - - - - 
Rigidity  - - - - 
Irritability - - - - 
Jumping - - - - 
Clonic convulsion - - - - 
Tonic convulsion - - - - 
II. Depression:     
Ptosis - - - - 
Sedation - - - - 
Sleep - - - - 
Loss of pinna reflex - - - - 
Ataxia - - - - 
Loss of muscle tone - - - - 
Analgesic - - - - 
III. Autonomic effects:     
Straub tail - - - - 
Laboured respiration - - - - 
Cyanosis - - - - 
Blanching - - - - 
Reddening - - - - 
IV. Number of animals dead    
+ Positive sign – Negative sign   
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TABLE NO. IV  
SHOWS THE RESULTS OF ACUTE TOXICITY STUDY OF “SANGU 
PARPAM” AT A DOSE OF 400 mg / 100 gm BODY WEIGHT OF ANIMAL 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I.  Stimulation :     
Hyper activity  - - - - 
Pyloerection  - - - - 
Twitching - - - - 
Rigidity  - - - - 
Irritability - - - - 
Jumping - - - - 
Clonic convulsion - - - - 
Tonic convulsion - - - - 
II. Depression:     
Ptosis - - - - 
Sedation - - - - 
Sleep - - - - 
Loss of pinna reflex - - - - 
Ataxia - - - - 
Loss of muscle tone - - - - 
Analgesic - - - - 
III. Autonomic effects:     
Straub tail - - - - 
Laboured respiration - - - - 
Cyanosis - - - - 
Blanching - - - - 
Reddening - - - - 
IV. Number of animals dead    
+ Positive sign – Negative sign   
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TABLE NO. V 
SHOWS THE RESULTS OF ACUTE TOXICITY STUDY OF “SANGU 
PARPAM” AT A DOSE OF 800 mg / 100 gm BODY WEIGHT OF ANIMAL 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I.  Stimulation :     
Hyper activity  - - - - 
Pyloerection  - - - - 
Twitching - - - - 
Rigidity  - - - - 
Irritability - - - - 
Jumping - - - - 
Clonic convulsion - - - - 
Tonic convulsion - - - - 
II. Depression:     
Ptosis - - - - 
Sedation - - - - 
Sleep - - - - 
Loss of pinna reflex - - - - 
Ataxia - - - - 
Loss of muscle tone - - - - 
Analgesic - - - - 
III. Autonomic effects:     
Straub tail - - - - 
Laboured respiration - - - - 
Cyanosis - - - - 
Blanching - - - - 
Reddening - - - - 
IV. Number of animals dead    
+ Positive sign – Negative sign   
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TABLE NO. VI 
SHOWS THE RESULTS OF ACUTE TOXICITY STUDY OF “SANGU 
PARPAM” AT A DOSE OF 1600 mg / 100 gm BODY WEIGHT OF 
ANIMAL 
Observation At 1 hr At 2 hrs At 4 hrs At 24 hrs 
I.  Stimulation :     
Hyper activity  - - - - 
Pyloerection  - - - - 
Twitching - - - - 
Rigidity  - - - - 
Irritability - - - - 
Jumping - - - - 
Clonic convulsion - - - - 
Tonic convulsion - - - - 
II. Depression:     
Ptosis - - - - 
Sedation - - - - 
Sleep - - - - 
Loss of pinna reflex - - - - 
Ataxia - - - - 
Loss of muscle tone - - - - 
Analgesic - - - - 
III. Autonomic effects:     
Straub tail - - - - 
Laboured respiration - - - - 
Cyanosis - - - - 
Blanching - - - - 
Reddening - - - - 
IV. Number of animals dead    
+ Positive sign – Negative sign 
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RESULT 
Acute Toxicity Study 
 
 The said parameters in acute toxicity study were observed on six group 
(Group I,II,III,IV, V, VI). Group II, III, IV, V, VI were administrated with drugs 
such as 100 mg, 200 mg, 400mg, 800mg, 1600mg, / animal respectively. 
 
 The results were tabulated in the table 1 to 6. From the table 2 to 6 its was 
found that the drug Sangu Parpam did not produce any mortality even upto 1600 
mg / animal.  
 
 Since it is practically difficult to administer more than 1600 mg/ animal 
(i.e) small species (Wistar albino rat) & there is no mortality of animals taken for 
the study it is unable to calculate the lethal dose in this preliminary acute toxicity 
study.  
 
 So, it is inferred that the drug is found to be safe upto 1600 mg / animal. 
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TABLE -VII 
CHANGES IN TABLE -VII 
CHANGES IN THE PARAMETERS OF WEIGHT AND HAEMATOLOGICAL INDICES IN 
GROUP I ANIMALS - CONTROL 
 
 
 
S.No. Blood 
At O' day 
(Mean) 
At 30th day At 60th day At 90th day 
1. 
WBC Total  
Count 
9800/cumm 9700/cumm 9800/cumm 9800/cumm 
2. Differential Count 
 Neutrophil 25% 25% 23% 24% 
 Eosinophil - - - - 
 Basophil - - - - 
 Lymphocyte 78% 78% 74% 74% 
 Monocyte - - - - 
3. Haemoglobin 74% 72% 72% 70% 
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TABLE -VIII 
CHANGES IN THE PARAMETERS OF WEIGHT AND HAEMATOLOGICAL INDICES IN 
GROUP II ANIMALS – 100mg/ BODY WEIGHT OF ANIMAL 
 
 
 
S.No. Blood 
At O' day 
(Mean) 
At 30th day At 60th day At 90th day 
1. 
WBC Total  
Count 
10200/cumm 10100/cumm 10000/cumm 10000/cumm 
2. Differential Count 
 Neutrophil 28% 25% 27% 28% 
 Eosinophil - - - - 
 Basophil - - - - 
 Lymphocyte 82% 84% 82% 80% 
 Monocyte - - - - 
3. Haemoglobin 74% 78% 76% 78% 
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TABLE -IX 
CHANGES IN THE PARAMETERS OF WEIGHT AND HAEMATOLOGICAL INDICES IN 
GROUP III ANIMALS – 200mg/ BODY WEIGHT OF ANIMAL 
 
 
 
S.No. Blood 
At O' day 
(Mean) 
At 30th day At 60th day At 90th day 
1. 
WBC Total  
Count 
10200/cumm 10200/cumm 10300/cumm 10200/cumm 
2. Differential Count 
 Neutrophil 26% 26% 22% 20% 
 Eosinophil - - - - 
 Basophil - - - - 
 Lymphocyte 84% 80% 82% 81% 
 Monocyte - - - - 
3. Haemoglobin 76% 74% 74% 78% 
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TABLE  - X 
CHANGES IN THE PARAMETERS OF 
BODY WEIGHT OF THE ANIMALS 
 
S.No 
Average Body Weight 
of Animal 
At 0 day At 30th day At 60th day At 90th day 
1. Group – I (Control) 100gm 100gm 103gm 104gm 
2. Group – II (200mg) 100gm 102gm 104gm 106gm 
3. Group – III (400mg) 100gm 104gm 106gm 108gm 
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Histopathological changes on Wistar Albino Rats 
(Control) 
  
Liver  :  No abnormality seen in hepatocytes, sinusoids 
Kidney :  No abnormality seen in glomeruli, Bowman‟s capsule, 
capillaries. 
Heart  :  No abnormalities seen in nuclei of myocytes, myocardium. 
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Histopathological changes on Wistar Albino Rats 
(Low dose – 100mg) 
 
Group II: 
   The effect of Sangu Parpam at the dose of 100mg.  
 
Microscopy: 
 
Liver  :  Section studied shows liver tissue with mild sinusoidal  
dilatation with focal congestion. 
Kidney  :  Section studied shows normal glomeruli with focal  
interstitial inflammation 
Heart  :  Section studied shows normal bundles of myocardial  
fibers. 
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Histopathological changes on Wistar Albino Rats 
(High dose – 200mg) 
 
Group III: 
   The effect of Sangu Parpam at the dose of 200mg.  
 
Microscopy: 
 
Liver  :  Section studied shows liver tissue with normal  
hepatocytes and  congested sinusoids.  
Kidney  :  Section studied shows normal glomeruli with focal  
interstitial edema and  inflammatory cell infiltration 
Heart  :  Section studied shows normal bundles of myocardial  
fibers. 
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SECTION OF LIVER - CONTROL 
 
 
SECTION OF KIDNEY - CONTROL  
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SECTION OF HEART - CONTROL  
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SECTION OF LIVER  
(100mg / 100gm body weight of the animal) 
 
 
SECTION OF LIVER  
(200mg / 100gm body weight of the animal) 
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SECTION OF KIDNEY 
(100mg / 100gm body weight of the animal) 
 
 
SECTION OF KIDNEY  
(200mg / 100gm body weight of the animal) 
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SECTION OF HEART  
(100mg / 100gm body weight of the animal) 
 
 
SECTION OF HEART  
(200mg / 100gm body weight of the animal) 
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CHRONIC TOXICITY STUDY RESULT 
 
 The mean value of body weight and hametalogical indices for the three 
groups of albino rats each group containing 5 animals with two different dose 
levels were observed and the results were tabulated in table 7, 8, 9, 10 for control, 
100 mg / 100 gm body weight of animal and 200 mg / 100 gm body weight of the 
animal and changes in the parameters of body weight of the animal respectively.  
 
 The drug doesnot show any mortality in this study, but it produces 
significant histopathological changes as congested sinusoids in liver, inflammatory 
infiltration in kidney at the dose of 200 mg / 100 gm body weight of animals. But 
there is no remarkable pathological changes at the dose of 100 mg / 100 gm body 
weight of animal. 
 
 Thus the drug produces mild toxic effect toxic effect on long term 
administration. 
  
107 
 
BIOSTATISTICAL ASPECTS 
 Biological assay refers to assessment of the potency of vitamins, hormones, 
toxicants and drugs of  all type by means of the responses produced when  doses 
are given to experimental animals. In every dose response situation, two 
components must be considered; the Stimulus and the Subject. 
 
 The stimulus is applied to the Subject as a stated dose namely 
concentration, weight, time or appropriate measure. The subject manifest a 
response, the level of intensity below which the response does not occur & above 
which the response occur, such a value has often been called threshold. But the 
term tolerance is now widely accepted.  
MEDIAN EFFECTIVE DOSE (E.D.50) 
 It is the dose which produces the desired response in half the animal 
population tested. 
MEDIAN LETHAL DOSE (LD 50) 
 It is the dose which kills half the population of the animal tested.  
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Table 11 
Acute Toxicity Study Analysis  
Group 
Dose in mg / body 
weight of animal 
No. of rats No. of rats died 
II 100 5 - 
III 200 5 - 
IV 400 5 - 
V 800 5 - 
VI 1600 mg 5 - 
 
 Since there was no mortality of the animal in acute toxicity study, lethal 
dose of drug could not be calculated.  
Table 12 
Chronic Toxicity Study Analysis 
Group 
Dose (mgs / body wt 
of animal) 
No. of rats Days 
No. of rats 
died 
I 100 mg 5 0 - 
   30 - 
   60 - 
   90 - 
II 200 mg 5 0 - 
   30 - 
   60 - 
   90 - 
 
 Lethal dose of the drug “SANGU PARPAM” can be calculated with 
higher dose level of the drug which can be done in further studies. 
 
109 
 
Concentration of Calcium, sodium and Potassium Before and 
After purification of Conch Shell and in finished product of 
Sangu Parpam 
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HAEMATOLOGICAL PARAMETERS 
 
 
Effect of Sangu Parpam on Haematological Profile WBC Count 
 
66
68
70
72
74
76
78
80
At 0 Day 30th Day 60th day 90th day
Effect of Sangu Parpam on Haematological Profile 
Haemoglobin 
Group I (Control)
Group II(100 mg)
Group III(200 mg)
9400
9500
9600
9700
9800
9900
10000
10100
10200
10300
10400
At 0 Day 30th Day 60th day 90th day
Group I (Control) Group II(100 mg) Group III(200 mg)
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Effect of Sangu Parpam on Haematological Profile Neutrophils 
 
 
Effect of Sangu Parpam on Haematological Profile Lymphocytes 
 
15
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At 0 Day 30th Day 60th day 90th day
Group I (Control) Group II(100 mg) Group III(200 mg)
68
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At 0 Day 30th Day 60th day 90th day
Group I (Control) Group II(100 mg) Group III(200 mg)
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CHANGES IN WEIGHT OF THE ALBINO RATS 
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DISCUSSION 
A study on “SANGU PARPAM” was conducted with an objective to find 
out, whether this drug has got any side effects or adverse reactions in long term 
administration.  
 The ICP – OES analysis revealed the presence of heavy metals like arsenic, 
cadmium, mercury and lead in below detection limit.  
 By scanning electron microscope (SEM), the sizes of the particles were 
analyzed. The particle size is about 400 nm. 
 The bio – chemical studies of the drug bring out the presence of calcium.  
 Toxicological studies reveal that in acute toxicity study, the single oral 
doses up to 1600 mg / 100 g body weight of the animal did not produce any 
morality even at the end of 24 hrs. 
 In chronic toxicity study, the oral dose level of 200 mg / 100 mg body 
weight of the animal produced some remarkable histopathological changes 
in liver, kidney and heart.  
 The hematological index shows no significant changes.  
 There is an increase in the weight and the results are statistically 
represented. 
 Bio – statistical measures to the acute and chronic toxicity studies show, the 
drug SANGU PARPAM is found to be safe upto 1600 mg / 100 g body 
weight of the animal in acute toxicity study, since there is no mortality the 
lethal dose of drug could not be calculated.  
 The chronic toxicity studies reveal some toxic effects due to long term 
administration.The dose administered for chronic toxicity studies in rats are 
relatively very high when compared to human dose level. The aim of giving 
such a high dose is to find out the type of toxicity produced by it. Moreover 
all these changes are warning about the adverse effect of Sangu Parpam in 
long term administration at clinical side. So the prescribed dose to the 
patients as said in the siddha literature is safe and recommended. 
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SUMMARY 
The drug “SANGU PARPAM” is indicated for the treatment of Elumburuki. 
 Aim of the dissertation is to rule out the acute and chronic toxicity of the 
drug by experimental studies on animal.  
 
 The ICP – OES analysis revealed the presence of heavy metals like arsenic, 
cadmium, mercury and lead in below detection limit and required 
concentration of calcium, sodium and potassium. 
 
 By scanning electron microscope (SEM), the sizes of the particles were 
analyzed. The particle size is about 400nm.  
 
 The bio – chemical studies of the drug bring out the presence of calcium. 
 
 Wistar albino rats bred in the animal house attached to the postgraduate, 
Department of Pharmacology, Govt. Siddha Medical College of 
Palayamkottai were used. Animals of both sexes were used. Animals 
weighing between 80 – 120 g were selected and fed with standard food and 
water.  
 
 Acute toxicity study were observed on six various groups (Group – I, Group 
– II, Group – III, Group – IV, Group – V, Group – VI). Group I is the 
control and Group II to VI were treated with the drug such as 100 mg, 200 
mg, 400 mg, 800 mg, 1600 mg / 100 g body weight of the animal 
respectively. It is being found that the drug “SANGU PARPAM” didn‟t 
produce any mortality even up to 1600 mg / 100 g body weight of the 
animal. So it is inferred that the drug is safe up to 1600 gm / 100 g body 
weight of the animal.  
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 Chronic toxicity studies were observed on 15 albino rats, divided into 3 
groups, each consisting of 5 animals. 2 doses were selected from the acute 
toxicity study – 100 mg and 200 mg respectively. These doses didn‟t have 
any acute toxicity effect and presumed to be safe for long term 
administration in animal.  
 
 The following details were recorded before the beginning of the drug 
administration. 
a. Weight of the animal 
b. Hematological indices 
 
 The above parameters were recorded every month and repeated at the end 
of the experiment.  
 
 The results are tabulated in statistical representation.  
 
 The animals were sacrificed at the end of the experiment and viscera‟s – 
liver, kidney, heart, were removed from each animal and preserved in 40% 
formalin for histopathological studies. The animal produced some 
remarkable histopathological in liver, kidney and heart.  
 
 The hematological index shows no significant changes.  
 
 Bio – statistical measures to the acute and chronic toxicity studies shows the 
drug “SANGU PARPAM” found to be safe up to 1600 mg / 100 gm body 
weight of the animal in acute toxicity study. Since there is no mortality, the 
lethal dose of drug could not be calculated.  
 
 The chronic toxicity studies reveal some toxic effects due to long term 
administration. 
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CONCLUSION 
 From the above studies it was concluded that the drug “SANGU 
PARPAM” produces mild histopathological changes during long term 
administration in animal dose ie 200 mg / 100 gm body weight of animal, but not 
in lower dose i.e. 100 mg / 100 gm body weight of animal. These changes are not 
significant in long term administration. So this drug is safe to the humanity in 
lower dose with suitable adjuvant (anupanam) for the treatment of Elumburuki, 
along with the advice of the physician to follow regular course of treatment (naal 
alavu), according to the patient‟s physical state and condition of the disease. 
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